Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Head and Neck Cancer

  Free Subscription


Articles published in Thyroid

Retrieve available abstracts of 427 articles:
HTML format



Single Articles


    September 2021
  1. DEKKER BL, Muller Kobold AC, Brouwers AH, Williams GRR, et al
    Bone Mineral Density in Adult Survivors of Pediatric Differentiated Thyroid Carcinoma: a longitudinal follow-up study.
    Thyroid. 2021 Sep 13. doi: 10.1089/thy.2021.0179.
    PubMed     Abstract available


    August 2021
  2. XU S, Huang H, Zhang X, Huang Y, et al
    Predictive value of serum thyroglobulin for structural recurrence following lobectomy for papillary thyroid carcinoma.
    Thyroid. 2021 Aug 3. doi: 10.1089/thy.2021.0209.
    PubMed     Abstract available


    July 2021
  3. OKAZAKI-HADA M, Maruoka A, Yamamoto M, Ito M, et al
    Poorly differentiated thyroid carcinoma coexisting with Graves' disease involving T3 thyrotoxicosis due to increased D1 and D2 activities.
    Thyroid. 2021 Jul 18. doi: 10.1089/thy.2021.0082.
    PubMed     Abstract available


    April 2021
  4. KIM DH, Kim SW, Kang P, Choi J, et al
    Near-infrared autofluorescence imaging may reduce temporary hypoparathyroidism in patients undergoing total thyroidectomy and central neck dissection.
    Thyroid. 2021 Apr 28. doi: 10.1089/thy.2021.0056.
    PubMed     Abstract available


    February 2021
  5. QIN YU, Wang JR, Wang Y, Iyer PC, et al
    Clinical Utility of Circulating Cell-free DNA Mutations in Anaplastic Thyroid Carcinoma.
    Thyroid. 2021 Feb 18. doi: 10.1089/thy.2020.0296.
    PubMed     Abstract available


    January 2021
  6. DIERKS C, Seufert J, Aumann K, Ruf J, et al
    The Lenvatinib/Pembrolizumab combination is an effective treatment option for anaplastic and poorly differentiated thyroid carcinoma.
    Thyroid. 2021 Jan 28. doi: 10.1089/thy.2020.0322.
    PubMed     Abstract available


    December 2020
  7. CONDELLO V, Nikitski AV, Foulkes W, Nikiforov YE, et al
    Prevalence of WWP1 Gene Mutations in Patients with Thyroid Nodules.
    Thyroid. 2020 Dec 29. doi: 10.1089/thy.2020.0919.
    PubMed     Abstract available


  8. CORRADO A, Aceto R, Silvestri R, Dell'Anno I, et al
    Pro64His (rs4644) polymorphism within galectin-3 is a risk factor of differentiated thyroid carcinoma and affects the transcriptome of thyrocytes engineered via CRISPR/Cas9 system.
    Thyroid. 2020 Dec 14. doi: 10.1089/thy.2020.0366.
    PubMed     Abstract available


    November 2020
  9. TAIEB D, Castinetti F
    PET imaging in medullary thyroid carcinoma: time for reappraisal?
    Thyroid. 2020 Nov 15. doi: 10.1089/thy.2020.0674.
    PubMed     Abstract available


  10. WONG KS, Dong F, Telatar M, Lorch J, et al
    Papillary Thyroid Carcinoma with High-Grade Features Versus Poorly Differentiated Thyroid Carcinoma: An Analysis of Clinicopathologic and Molecular Features and Outcome.
    Thyroid. 2020 Nov 4. doi: 10.1089/thy.2020.0668.
    PubMed     Abstract available


  11. BOGDANOVA TI, Saenko VA, Hashimoto Y, Hirokawa M, et al
    Papillary thyroid carcinoma in Ukraine after Chernobyl and in Japan after Fukushima: different histopathological scenarios.
    Thyroid. 2020 Nov 4. doi: 10.1089/thy.2020.0308.
    PubMed     Abstract available


    October 2020
  12. KOTWAL A, Erickson D, Geske J, Hay ID, et al
    Predicting Outcomes in Sporadic and Hereditary Medullary Thyroid Carcinoma over Two Decades.
    Thyroid. 2020 Oct 27. doi: 10.1089/thy.2020.0167.
    PubMed     Abstract available


  13. VALVO V, Iesato A, Kavanagh TR, Priolo C, et al
    Fine-tuning lipid metabolism by targeting mitochondria-associated Acetyl-CoA-Carboxylase 2 in BRAFV600E papillary thyroid carcinoma.
    Thyroid. 2020 Oct 27. doi: 10.1089/thy.2020.0311.
    PubMed     Abstract available


    August 2020
  14. SONG HJ, Chen X, Jiao Q, Qiu ZL, et al
    HIF-1alpha-mediated TERT Activation Inducing Autophagy through mTOR Promotes Papillary Thyroid Carcinoma Progression During Hypoxia Stress.
    Thyroid. 2020 Aug 9. doi: 10.1089/thy.2020.0023.
    PubMed     Abstract available


    July 2020
  15. AGATE L, Puleo L, Giani C, Valerio L, et al
    Symptomatic and asymptomatic biliary disorders during lenvatinib treatment for advanced thyroid cancer is an underestimated problem.
    Thyroid. 2020 Jul 29. doi: 10.1089/thy.2020.0245.
    PubMed     Abstract available


    June 2020
  16. SAWKA AM, Baxter N, Gafni A, Ezzat S, et al
    Response: Letter to Editor "A prospective mixed-methods study of decision-making on surgery or active surveillance for low risk papillary thyroid cancer".
    Thyroid. 2020 Jun 19. doi: 10.1089/thy.2020.0495.
    PubMed     Abstract available


  17. PEKOVA B, Sykorova V, Dvorakova S, Vaclavikova E, et al
    RET, NTRK, ALK, BRAF and MET fusions in a large cohort of pediatric papillary thyroid carcinomas.
    Thyroid. 2020 Jun 4. doi: 10.1089/thy.2019.0802.
    PubMed     Abstract available


  18. YIN N, Sherman SI, Pak Y, Litofsky D, et al
    The De Novo Detection of Anti-thyroglobulin Antibodies and Differentiated Thyroid Cancer Recurrence.
    Thyroid. 2020 Jun 2. doi: 10.1089/thy.2020.0467.
    PubMed     Abstract available


  19. MIYAUCHI A, Ito Y, Davies L
    "A Prospective Mixed-Methods Study of Decision-Making on Surgery or Active Surveillance for Low-Risk Papillary Thyroid Cancer" by Sawka AM et al. (Thyroid 2020 Apr 8. doi: 10.1089/thy.2019.0592. Online ahead of print).
    Thyroid. 2020 Jun 2. doi: 10.1089/thy.2020.0469.
    PubMed     Abstract available


    May 2020
  20. ROSARIO PW, Cortes MC
    Anti-thyroglobulin Antibodies and Differentiated Thyroid Cancer Recurrence.
    Thyroid. 2020 May 27. doi: 10.1089/thy.2020.0302.
    PubMed     Abstract available


  21. SMULEVER A, Barrio Lower Daniele S, Damiano G, Pitoia F, et al
    Complete surgical resection after Dabrafenib plus Trametinib treatment in a patient with locally advanced and metastatic anaplastic thyroid carcinoma with a BRAF V600E mutation.
    Thyroid. 2020 May 12. doi: 10.1089/thy.2020.0251.
    PubMed     Abstract available


  22. HODAK SP, Duh QY
    The American Association of Endocrine Surgeons (AAES) Guidelines for the Definitive Surgical Management of Thyroid Disease in Adults
    Thyroid. 2020 May 10. doi: 10.1089/thy.2020.0209.
    PubMed     Abstract available


  23. KAWANO S, Miyauchi A, Ito Y
    Routine chest CT at presentation does not identify distant metastasis in cT1aN0 papillary thyroid carcinoma.
    Thyroid. 2020 May 5. doi: 10.1089/thy.2020.0073.
    PubMed     Abstract available


    April 2020
  24. HALE PM, Ali AK, Buse JB, McCullen MK, et al
    Medullary Thyroid Carcinoma Surveillance Study: a Case-Series Registry.
    Thyroid. 2020 Apr 22. doi: 10.1089/thy.2019.0591.
    PubMed     Abstract available


  25. DIAS-SANTAGATA D, Lennerz JK, Sadow PM, Frazier RP, et al
    Response to RET-Specific Therapy in <i>RET</i> Fusion-Positive Anaplastic Thyroid Carcinoma.
    Thyroid. 2020 Apr 15. doi: 10.1089/thy.2019.0477.
    PubMed     Abstract available


  26. XU B, Fuchs TL, Dogan S, Landa I, et al
    Dissecting Anaplastic Thyroid Carcinoma (ATC): A Comprehensive Clinical, histologic, Immunophenotypic, and Molecular Study of 360 Cases.
    Thyroid. 2020 Apr 13. doi: 10.1089/thy.2020.0086.
    PubMed     Abstract available


    March 2020
  27. GEMIGNANI F, Romei C, Ciampi R, Corrado A, et al
    Polymorphisms within the RET proto-oncogene and risk of sporadic medullary thyroid carcinoma.
    Thyroid. 2020 Mar 31. doi: 10.1089/thy.2019.0352.
    PubMed     Abstract available


  28. LEE YA, Im SW, Jung KC, Chung EJ, et al
    Predominant DICER1 pathogenic Variants in Pediatric Follicular Thyroid Carcinomas.
    Thyroid. 2020 Mar 31. doi: 10.1089/thy.2019.0233.
    PubMed     Abstract available


  29. PAPALEONTIOU M, Haymart MR
    Too much of a good thing? A cautionary tale of thyroid cancer overdiagnosis and overtreatment.
    Thyroid. 2020 Mar 11. doi: 10.1089/thy.2020.0185.
    PubMed     Abstract available


  30. AHMADI S, Gonzalez Sepulveda JM, Talbott M, Reed S, et al
    Patient preferences around extent of surgery in low-risk thyroid cancer: A discrete-choice experiment.
    Thyroid. 2020 Mar 6. doi: 10.1089/thy.2019.0590.
    PubMed     Abstract available


  31. SAWKA AM, Ghai S, Yoannidis T, Rotstein L, et al
    A prospective mixed-methods study of decision-making on surgery or active surveillance for low risk papillary thyroid cancer.
    Thyroid. 2020 Mar 4. doi: 10.1089/thy.2019.0592.
    PubMed     Abstract available


  32. KLUBO-GWIEZDZINSKA J, Chen X
    Targeting Integrins with Radiolabeled RGD Analogs for Radiotheranostics of Metastatic Radioactive Iodine Non-Responsive Thyroid Cancer - New Avenues in Personalized Medicine.
    Thyroid. 2020 Mar 2. doi: 10.1089/thy.2020.0169.
    PubMed     Abstract available


  33. KIM M, Kim SJ, Xu Z, Ha SY, et al
    <i>BRAF<sup>V600E</i></sup> Transduction of SV40-immortalized Normal Human Thyroid Cell Line Induces Dedifferentiated Thyroid Carcinogenesis in a Mouse Xenograft Model.
    Thyroid. 2020 Mar 2. doi: 10.1089/thy.2019.0301.
    PubMed     Abstract available


    February 2020
  34. YIP L
    Thoughtful Utilization of Molecular Testing in Refining Thyroid Nodule Risk Assessment: Don't Throw Out the Baby.
    Thyroid. 2020 Feb 28. doi: 10.1089/thy.2020.0148.
    PubMed     Abstract available


  35. JHIANG SM, Konda B, Sipos JA, Nabhan F, et al
    Prospects for Re-differentiating Agents in the Use of Radioactive Iodine Therapy for Thyroid Cancer.
    Thyroid. 2020 Feb 27. doi: 10.1089/thy.2020.0143.
    PubMed     Abstract available


  36. NIES M, Cantineau AEP, Arts EGJM, van den Berg MH, et al
    Long-Term Effects of Radioiodine Treatment on Female Fertility in Survivors of Childhood Differentiated Thyroid Carcinoma.
    Thyroid. 2020 Feb 20. doi: 10.1089/thy.2019.0560.
    PubMed     Abstract available


  37. DANILOVIC DLS, Castroneves LA, Suemoto CK, Elias LO, et al
    Is there a difference between minimal and gross extension into the strap muscles for the risk of recurrence in papillary thyroid carcinomas?
    Thyroid. 2020 Feb 14. doi: 10.1089/thy.2019.0753.
    PubMed     Abstract available


  38. NIEDERLE MB, Scheuba C, Riss P, Selberherr A, et al
    Early diagnosis of medullary thyroid cancer: Are calcitonin stimulation tests still indicated in the era of highly sensitive calcitonin immunoassays?
    Thyroid. 2020 Feb 14. doi: 10.1089/thy.2019.0785.
    PubMed     Abstract available


  39. CESAREO R, Pacella CM, Pasqualini V, Campagna G, et al
    Laser Ablation versus Radiofrequency Ablation for benign non-functioning thyroid nodules: Six-month results of a randomised, parallel, open-label, trial (LARA trial).
    Thyroid. 2020 Feb 14. doi: 10.1089/thy.2019.0660.
    PubMed     Abstract available


  40. YEHIA L, Eng C
    The APCs of PTCs: Adenomatous Polyposis Syndrome and the Thyroid.
    Thyroid. 2020 Feb 11. doi: 10.1089/thy.2020.0109.
    PubMed     Abstract available


  41. ZHAO Y, Yu T, Chen L, Xie D, et al
    A Germline <i>CHEK2</i> Mutation in a Family with Papillary Thyroid Cancer.
    Thyroid. 2020 Feb 11. doi: 10.1089/thy.2019.0774.
    PubMed     Abstract available


  42. QU N, Shi X, Zhao JJ, Guan H, et al
    Genomic and Transcriptomic Characterization of Sporadic Medullary Thyroid Carcinoma.
    Thyroid. 2020 Feb 7. doi: 10.1089/thy.2019.0531.
    PubMed     Abstract available


  43. TESSLER FN
    Title: Commentary on: "Investigating the effect of thyroid nodule location on the risk of thyroid cancer," Jasim et al. Alternate title: Thyroid nodules and real estate: location matters.
    Thyroid. 2020 Feb 7. doi: 10.1089/thy.2020.0090.
    PubMed     Abstract available


  44. PEREZ-SOTO RH, Velazquez-Fernandez D, Arellano-Gutierrez G, Chapa Ibarguengoitia M, et al
    Preoperative and postoperative risk stratification of thyroid papillary microcarcinoma. A comparative study between Kuma criteria and 2015 ATA guidelines risk stratification.
    Thyroid. 2020 Feb 7. doi: 10.1089/thy.2019.0698.
    PubMed     Abstract available


  45. JIANG M, Li C, Tang S, Lv W, et al
    Nomogram based on shear-wave elastography radiomics can improve preoperative cervical lymph node staging for papillary thyroid carcinoma.
    Thyroid. 2020 Feb 6. doi: 10.1089/thy.2019.0780.
    PubMed     Abstract available


  46. NIEMINEN TT, Walker CJ, Olkinuora A, Genutis LK, et al
    Thyroid carcinomas that occur in familial adenomatous polyposis patients recurrently harbor somatic variants in APC, BRAF, and KTM2D.
    Thyroid. 2020 Feb 5. doi: 10.1089/thy.2019.0561.
    PubMed     Abstract available


  47. REN Y, Kyriazidis N, Faquin WC, Soylu S, et al
    The presence of Hurthle cells does not increase the risk of malignancy in most Bethesda categories in thyroid fine-needle aspirates.
    Thyroid. 2020 Feb 4. doi: 10.1089/thy.2019.0190.
    PubMed     Abstract available


  48. THOMAS J, Haertling T
    AIBx, artificial intelligence model to risk stratify thyroid nodules.
    Thyroid. 2020 Feb 4. doi: 10.1089/thy.2019.0752.
    PubMed     Abstract available


    January 2020
  49. GUAN H, Toraldo G, Cerda SR, Godley FA, et al
    Utilities of RAS mutations in pre-operative fine needle biopsies for decision-making for thyroid nodule management: results from a single-center prospective cohort.
    Thyroid. 2020 Jan 29. doi: 10.1089/thy.2019.0116.
    PubMed     Abstract available


  50. TRIMBOLI P, Piccardo A, Signore A, Valabrega S, et al
    Patient age is an independent risk factor of relapse of differentiated thyroid carcinoma and improves the performance of the ATA stratification system.
    Thyroid. 2020 Jan 23. doi: 10.1089/thy.2019.0688.
    PubMed     Abstract available


  51. SARACYN M, Lubas A, Bober B, Kowalski L, et al
    <b>Recombinant human thyrotropin worsens renal cortical perfusion and renal function in patients after total thyroidectomy due to differentiated thyroid cancer</b>.
    Thyroid. 2020 Jan 22. doi: 10.1089/thy.2019.0372.
    PubMed     Abstract available


  52. LI M, Brito JP, Vaccarella S
    Long term declines of thyroid cancer mortality: an international age-period-cohort analysis.
    Thyroid. 2020 Jan 22. doi: 10.1089/thy.2019.0684.
    PubMed     Abstract available


  53. LIU L, Zhang X, Tian T, Huang R, et al
    Prognostic value of pre-ablation stimulated thyroglobulin in children and adolescents with differentiated thyroid cancer.
    Thyroid. 2020 Jan 22. doi: 10.1089/thy.2019.0585.
    PubMed     Abstract available


  54. GONZALEZ-VELAZQUEZ CD, O'Malley QF, Yue LE, Urken ML, et al
    Letter to the editor: Treatment decisions in thyroid microcarcinomas: Identifying gaps in knowledge to empower our patients.
    Thyroid. 2020 Jan 22. doi: 10.1089/thy.2019.0451.
    PubMed     Abstract available


  55. PERSICHETTI A, Di Stasio E, Coccaro C, Graziano FM, et al
    Inter- and Intra-Observer Agreement in the Assessment of Thyroid Nodule Ultrasound Features and Classification systems: A Blinded Multicenter Study.
    Thyroid. 2020 Jan 17. doi: 10.1089/thy.2019.0360.
    PubMed     Abstract available


  56. LEE YK, Hwangbo Y, Lee S, Lee DE, et al
    Aspirin use is not associated with lower thyroid cancer risk: A nationwide nested case-control study.
    Thyroid. 2020 Jan 17. doi: 10.1089/thy.2019.0641.
    PubMed     Abstract available


  57. SANABRIA A
    Experience with active surveillance of thyroid microcarcinomalow-risk carcinoma in a developing country.
    Thyroid. 2020 Jan 17. doi: 10.1089/thy.2019.0522.
    PubMed     Abstract available


  58. JACK GA, Sternberg SB, Aronson MD, Mukamal KJ, et al
    <b>Non-Diagnostic Fine-Needle Aspiration Biopsy of Thyroid Nodules: Outcomes and Determinants</b>.
    Thyroid. 2020 Jan 17. doi: 10.1089/thy.2019.0140.
    PubMed     Abstract available


  59. PAPARODIS R, Karvounis E, Bantouna D, Chourpiliadis C, et al
    Incidentally discovered papillary thyroid microcarcinomas are more frequently found in patients with chronic lymphocytic thyroiditis than with multinodular goiter or Graves disease.
    Thyroid. 2020 Jan 17. doi: 10.1089/thy.2019.0347.
    PubMed     Abstract available


  60. MORENO I, Hirsch D, Duskin-Bitan H, Diker-Cohen T, et al
    Response to Therapy Assessment in Intermediate-Risk Thyroid Cancer Patients- Is rhTSH Stimulation Required?
    Thyroid. 2020 Jan 13. doi: 10.1089/thy.2019.0431.
    PubMed     Abstract available


  61. HE H, Li W, Comiskey DF Jr, Liyanarachchi S, et al
    A truncating germline mutation of TINF2 in individuals with thyroid cancer or melanoma results in longer telomeres.
    Thyroid. 2020 Jan 13. doi: 10.1089/thy.2019.0156.
    PubMed     Abstract available


  62. VAN VELSEN EFS, Visser WE, van den Berg S, Kam BLR, et al
    Longitudinal Analysis of the Effect of Radioiodine Therapy on Ovarian Reserve in Females with Differentiated Thyroid Cancer.
    Thyroid. 2020 Jan 13. doi: 10.1089/thy.2019.0504.
    PubMed     Abstract available


  63. OH JM, Baek SH, Gangadaran P, Hong CM, et al
    A novel tyrosine kinase inhibitor can augment radioactive iodine uptake through endogenous sodium/iodide symporter (NIS) expression in anaplastic thyroid cancer.
    Thyroid. 2020 Jan 13. doi: 10.1089/thy.2018.0626.
    PubMed     Abstract available


  64. SONG E, Kim M, Kim EY, Kim BH, et al
    Lenvatinib for radioactive iodine-refractory differentiated thyroid carcinoma and candidate biomarkers associated with survival: A multicenter study in Korea.
    Thyroid. 2020 Jan 7. doi: 10.1089/thy.2019.0476.
    PubMed     Abstract available


  65. ZAFEREO M, McIver B, Vargas S, Dominguez Ruiz-Tagle JM, et al
    A THYROID GENETIC CLASSIFIER CORRECTLY PREDICTS BENIGN NODULES WITH INDETERMINATE CYTOLOGY: TWO-INDEPENDENT MULTICENTER, PROSPECTIVE VALIDATION TRIALS.
    Thyroid. 2020 Jan 7. doi: 10.1089/thy.2019.0490.
    PubMed     Abstract available


  66. ZHANG M, Tufano RP, Russell J, Zhang Y, et al
    Ultrasound-guided radiofrequency ablation versus surgery for low risk papillary thyroid micro-carcinoma: results of over 5 years follow-up.
    Thyroid. 2020 Jan 7. doi: 10.1089/thy.2019.0147.
    PubMed     Abstract available


  67. SUGINO K, Nagahama M, Kitagawa W, Ohkuwa K, et al
    Risk stratification of pediatric patients with differentiated thyroid cancer: Is total thyroidectomy necessary for patients at any risk? .
    Thyroid. 2020 Jan 7. doi: 10.1089/thy.2019.0231.
    PubMed     Abstract available


  68. JASIM S, Baranski T, Teefey S, Middleton WD, et al
    Investigating the effect of thyroid nodule location on the risk of thyroid cancer.
    Thyroid. 2020 Jan 7. doi: 10.1089/thy.2019.0478.
    PubMed     Abstract available


  69. YOSHIDA Y, Horiuchi K, Okamoto T
    Patients' view on the management of papillary thyroid microcarcinoma: active surveillance or surgery.
    Thyroid. 2020 Jan 7. doi: 10.1089/thy.2019.0420.
    PubMed     Abstract available


  70. JENSEN CB, Saucke MC, Francis DO, Voils CI, et al
    From Overdiagnosis to Overtreatment of Low-risk Thyroid Cancer: A Thematic Analysis of Attitudes and Beliefs of Endocrinologists, Surgeons, and Patients.
    Thyroid. 2020 Jan 7. doi: 10.1089/thy.2019.0587.
    PubMed     Abstract available


  71. HARRIES V, McGill MR, Tuttle RM MD, Shaha AR MD, et al
    Management of Retropharyngeal Lymph Node Metastases in Differentiated Thyroid Carcinoma.
    Thyroid. 2020 Jan 5. doi: 10.1089/thy.2019.0359.
    PubMed     Abstract available


    December 2019
  72. LEROY L, Bonhomme B, Le Moulec S, Soubeyran I, et al
    Remarkable Response to Ceritinib and Brigatinib in an Anaplastic Lymphoma Kinase-Rearranged Anaplastic Thyroid Carcinoma previously treated with Crizotinib.
    Thyroid. 2019 Dec 31. doi: 10.1089/thy.2019.0202.
    PubMed     Abstract available


  73. SONG E, Ahn J, Jeon M, Lee SM, et al
    Estimating the growth rate of lung metastases in differentiated thyroid carcinoma: Response Evaluation Criteria in Solid Tumors or doubling time?
    Thyroid. 2019 Dec 27. doi: 10.1089/thy.2019.0341.
    PubMed     Abstract available


  74. YUAN Q, Wu G, Hou J, Liao X, et al
    Correlation between electrophysiological changes and outcomes of vocal cord function in 1764 recurrent laryngeal nerves with visual integrity during thyroidectomy.
    Thyroid. 2019 Dec 27. doi: 10.1089/thy.2019.0361.
    PubMed     Abstract available


  75. PARIHAR AS, Mittal BR, Kumar R, Shukla J, et al
    68Ga-DOTA-RGD2 PET/CT in radioiodine (131I) refractory thyroid cancer - Prospective comparison of diagnostic accuracy with 18F-FDG PET/CT and evaluation towards potential theranostics.
    Thyroid. 2019 Dec 23. doi: 10.1089/thy.2019.0450.
    PubMed     Abstract available


  76. JUN JK, Hwang SY, Hong S, Suh M, et al
    Association of screening by thyroid ultrasonography with mortality in thyroid cancer: a case-control study using data from two national surveys.
    Thyroid. 2019 Dec 23. doi: 10.1089/thy.2019.0460.
    PubMed     Abstract available


  77. MASAKI C, Sugino K, Saito N, Akaishi J, et al
    Efficacy and limitations of lenvatinib therapy for radioiodine-refractory differentiated thyroid cancer: real-world experiences.
    Thyroid. 2019 Dec 19. doi: 10.1089/thy.2019.0221.
    PubMed     Abstract available


  78. NERVO A, Ragni A, Gallo M, Ferraris A, et al
    SYMPTOMATIC BILIARY DISORDERS DURING LENVATINIB TREATMENT FOR THYROID CANCER: AN UNDERESTIMATED PROBLEM?
    Thyroid. 2019 Dec 19. doi: 10.1089/thy.2019.0355.
    PubMed     Abstract available


  79. SHEN M, Wang C, Li Z
    Letter to the Editor regarding the article "Impact of extranodal extension on risk stratification in papillary thyroid carcinoma".
    Thyroid. 2019 Dec 17. doi: 10.1089/thy.2019.0287.
    PubMed     Abstract available


  80. BUSAIDY N
    The Year in Medical Thyroidology Review: Current Challenges and Future Directions.
    Thyroid. 2019 Dec 16. doi: 10.1089/thy.2019.0792.
    PubMed     Abstract available


  81. LI G, Li R, Song L, Chen W, et al
    Implications of extrathyroidal extension invading only the strap muscles in papillary thyroid carcinomas.
    Thyroid. 2019 Dec 13. doi: 10.1089/thy.2018.0801.
    PubMed     Abstract available


  82. SAWKA AM, Gagliardi AR, Haymart MR, Sturgeon C, et al
    A Survey of American Thyroid Association Members Regarding the 2015 Adult Thyroid Nodule and Differentiated Thyroid Cancer Clinical Practice Guidelines.
    Thyroid. 2019 Dec 13. doi: 10.1089/thy.2019.0486.
    PubMed     Abstract available


  83. CHENG SY
    The Year in Basic Thyroidology.
    Thyroid. 2019 Dec 10. doi: 10.1089/thy.2019.0768.
    PubMed     Abstract available


  84. CRAIG SJ, Bysice A, Nakoneshny SC, Pasieka JL, et al
    THE IDENTIFICATION OF INTRA-OPERATIVE RISK FACTORS CAN REDUCE, BUT NOT EXCLUDE, THE NEED FOR COMPLETION THYROIDECTOMY IN LOW-RISK PAPILLARY THYROID CANCER PATIENTS.
    Thyroid. 2019 Dec 6. doi: 10.1089/thy.2019.0274.
    PubMed     Abstract available


  85. CHOI Y, Jung SL
    Efficacy and safety of thermal ablation techniques for the treatment of primary papillary thyroid microcarcinoma: a systematic review and meta-analysis.
    Thyroid. 2019 Dec 4. doi: 10.1089/thy.2019.0707.
    PubMed     Abstract available


  86. PARK JL, Jeon S, Seo E, Bae DH, et al
    Comprehensive DNA methylation profiling identifies novel diagnostic biomarkers for thyroid cancer.
    Thyroid. 2019 Dec 4. doi: 10.1089/thy.2019.0011.
    PubMed     Abstract available


  87. VYDRO L, Kitahara CM, Lubin JH, Schneider AB, et al
    Among Individuals Irradiated for Benign Conditions in Childhood, Developing Thyroid Cancer Does Not Affect All-cause Survival.
    Thyroid. 2019 Dec 4. doi: 10.1089/thy.2019.0439.
    PubMed     Abstract available


  88. HUILLARD O, Jouinot A, Tlemsani C, Brose MS, et al
    Body Composition in Patients with Radioactive Iodine-Refractory, Advanced Differentiated Thyroid Cancer Treated with Sorafenib or Placebo: A Retrospective Analysis of the Phase III DECISION Trial.
    Thyroid. 2019;29:1820-1827.
    PubMed     Abstract available


    November 2019
  89. CHO SJ, Baek JH, Chung SR, Choi YJ, et al
    Thermal ablation for Small Papillary Thyroid Cancer: A Systematic Review.
    Thyroid. 2019 Nov 18. doi: 10.1089/thy.2019.0377.
    PubMed     Abstract available


  90. BONGIOVANNI M, Sykiotis GP, La Rosa S, Bisig B, et al
    Macrofollicular variant of follicular thyroid carcinoma: a rare, underappreciated pitfall in the diagnosis of thyroid carcinoma.
    Thyroid. 2019 Nov 8. doi: 10.1089/thy.2018.0607.
    PubMed     Abstract available


    October 2019
  91. MASOODI T, Siraj AK, Siraj S, Azam S, et al
    Whole Exome Sequencing of Matched Primary and Metastatic Papillary Thyroid Cancer.
    Thyroid. 2019 Oct 31. doi: 10.1089/thy.2019.0052.
    PubMed     Abstract available


  92. HILLIER K, Hughes A, Shamberger R, Shusterman S, et al
    A Novel ALK Fusion in Pediatric Medullary Thyroid Carcinoma.
    Thyroid. 2019 Oct 25. doi: 10.1089/thy.2019.0041.
    PubMed     Abstract available


  93. ITO Y, Miyauchi A, Kudo T, Higashiyama T, et al
    Kinetic Analysis of Growth Activity in Enlarging Papillary Thyroid Microcarcinomas.
    Thyroid. 2019 Oct 25. doi: 10.1089/thy.2019.0396.
    PubMed     Abstract available


  94. IRAVANI A, Solomon B, Pattison DA, Jackson P, et al
    Mitogen-activated protein kinase pathway inhibition for re-differentiation of radioiodine-refractory differentiated thyroid cancer: an evolving protocol.
    Thyroid. 2019 Oct 22. doi: 10.1089/thy.2019.0143.
    PubMed     Abstract available


  95. CHINTAKUNTLAWAR A, Yin J, Foote RL, Kasperbauer JL, et al
    A Phase 2 Study of Pembrolizumab Combined with Chemoradiotherapy as Initial Treatment for Anaplastic Thyroid Cancer.
    Thyroid. 2019 Oct 9. doi: 10.1089/thy.2019.0086.
    PubMed     Abstract available


  96. OH HS, Shin DY, Kim M, Park SY, et al
    Extended Real-World Observation of Patients Treated with Sorafenib for Radioactive Iodine-Refractory Differentiated Thyroid Carcinoma and Impact of Lenvatinib Salvage Treatment: A Korean Multicenter Study.
    Thyroid. 2019 Oct 8. doi: 10.1089/thy.2019.0246.
    PubMed     Abstract available


  97. FUZIWARA CS, Saito KC, Kimura ET
    Thyroid follicular cell loss of differentiation induced by miRNA miR-17-92 cluster is attenuated by CRISPR/Cas9n gene silencing in anaplastic thyroid cancer.
    Thyroid. 2019 Oct 3. doi: 10.1089/thy.2018.0601.
    PubMed     Abstract available


  98. JAIN NK, Mostoufi-Moab S, Hawkes CP, Nelson ND, et al
    Extrathyroidal Extension is an Important Predictor of Regional Lymph Node Metastasis in Pediatric Differentiated Thyroid Cancer.
    Thyroid. 2019 Oct 1. doi: 10.1089/thy.2019.0229.
    PubMed     Abstract available


    September 2019
  99. IANNI F, Pascucci D, Paragliola RM, Rota CA, et al
    Follow-up or surgery for indeterminate thyroid nodules: could the CUT score application be a support for decision making in the preoperative assessment?
    Thyroid. 2019 Sep 25. doi: 10.1089/thy.2018.0649.
    PubMed     Abstract available


  100. TERROIR M, Caramella C, Borget I, Bidault S, et al
    F-18-Dopa PET/CT is more sensitive than whole body MRI for the localization of persistent/recurrent disease of medullary thyroid cancer patients.
    Thyroid. 2019 Sep 18. doi: 10.1089/thy.2018.0351.
    PubMed     Abstract available


  101. KOHLER H, Latteyer S, Hoenes S, Theurer S, et al
    Increased ALK activity induces a poorly differentiated thyroid carcinoma in mice.
    Thyroid. 2019 Sep 16. doi: 10.1089/thy.2018.0526.
    PubMed     Abstract available


  102. ZAHEDI A, Bondaz L, Rajaraman M, Leslie WD, et al
    Risk for Thyroid Cancer Recurrence Is Higher In Men Than In Women Independent of Disease Stage At Presentation.
    Thyroid. 2019 Sep 16. doi: 10.1089/thy.2018.0775.
    PubMed     Abstract available


  103. ULLMANN TM, Gray KD, Limberg J, Stefanova D, et al
    Insurance Status Affects Extent of Treatment for Patients with Papillary Thyroid Carcinoma.
    Thyroid. 2019 Sep 10. doi: 10.1089/thy.2019.0245.
    PubMed     Abstract available


  104. MEMON A, Rogers I, Paudyal P, Sundin J, et al
    Dental x-rays and the risk of thyroid cancer and meningioma: A systematic review and meta-analysis of current epidemiological evidence.
    Thyroid. 2019 Sep 10. doi: 10.1089/thy.2019.0105.
    PubMed     Abstract available


  105. LEE EK, Kim SM, Kim BH, Kim MJ, et al
    Lesion-based Evaluation Predicts Treatment Response to Lenvatinib For Radioactive Iodine-Refractory Differentiated Thyroid Cancer: A Korean Multicenter Retrospective Study.
    Thyroid. 2019 Sep 4. doi: 10.1089/thy.2019.0022.
    PubMed     Abstract available


    August 2019
  106. CHUNG JH, Park J, Kim JW, Park H, et al
    Multifocality in a Patient with Cribriform-Morular Variant of Papillary Thyroid Carcinoma is an Important Clue for the Diagnosis of Familial Adenomatous Polyposis.
    Thyroid. 2019 Aug 30. doi: 10.1089/thy.2019.0261.
    PubMed     Abstract available


  107. GOLDNER W, Angell TE, McAdoo SL, Babiarz J, et al
    Molecular Variants and Their Risks for Malignancy in Cytologically Indeterminate Thyroid Nodules.
    Thyroid. 2019 Aug 30. doi: 10.1089/thy.2019.0278.
    PubMed     Abstract available


  108. WU D, Ylli D, Heimlich SL, Burman KD, et al
    I-124 PET/CT versus conventional radioiodine imaging in differentiated thyroid cancer: a review.
    Thyroid. 2019 Aug 27. doi: 10.1089/thy.2018.0598.
    PubMed     Abstract available


  109. BULLOCK M, Lim G, Zhu Y, Aberg H, et al
    The ETS Factor ETV5 Activates the Mutant TERT Promoter in Thyroid Cancer.
    Thyroid. 2019 Aug 27. doi: 10.1089/thy.2018.0314.
    PubMed     Abstract available


  110. SUGITANI I, Ito Y, Miyauchi A, Imai T, et al
    Active Surveillance versus Immediate Surgery: Questionnaire Survey on the Current Treatment Strategy for Adult Patients with Low-risk Papillary Thyroid Microcarcinoma in Japan.
    Thyroid. 2019 Aug 23. doi: 10.1089/thy.2019.0211.
    PubMed     Abstract available


  111. LEE DH, Kim YK, Yu HW, Choi JY, et al
    Computed Tomography (CT) for Detecting Cervical Lymph Node Metastasis in Patients who have Papillary Thyroid Microcarcinoma with Tumor Characteristics Appropriate for Active Surveillance.
    Thyroid. 2019 Aug 22. doi: 10.1089/thy.2019.0100.
    PubMed     Abstract available


  112. HO AS, Luu M, Zalt C, Morris LGT, et al
    Mortality risk of nonoperative papillary thyroid carcinoma: a corollary for active surveillance.
    Thyroid. 2019 Aug 13. doi: 10.1089/thy.2019.0060.
    PubMed     Abstract available


  113. BORRELLI N, Panebianco F, Condello V, Barletta JA, et al
    Characterization of activating mutations of the <i>MEK1</i> gene in papillary thyroid carcinomas.
    Thyroid. 2019 Aug 13. doi: 10.1089/thy.2019.0065.
    PubMed     Abstract available


  114. NICHOLSON K, Roberts MS, McCoy KL, Carty SE, et al
    Molecular Testing Versus Diagnostic Lobectomy in Bethesda III/IV Thyroid Nodules: A Cost-Effectiveness Analysis.
    Thyroid. 2019 Aug 13. doi: 10.1089/thy.2018.0779.
    PubMed     Abstract available


  115. WONG KS, Lorch J, Alexander EK, Marqusee E, et al
    Prognostic Significance of Extent of Invasion in Poorly Differentiated Thyroid Carcinoma.
    Thyroid. 2019 Aug 9. doi: 10.1089/thy.2019.0263.
    PubMed     Abstract available


  116. CHO SJ, Suh CH, Baek JH, Chung SR, et al
    Active Surveillance for Small Papillary Thyroid Cancer: A Systematic Review and Meta-Analysis.
    Thyroid. 2019 Aug 1. doi: 10.1089/thy.2019.0159.
    PubMed     Abstract available


    July 2019
  117. QI XP, Jin BY, Li PF, Wang S, et al
    RET S409Y Germline Mutation and Associated Medullary Thyroid Carcinoma.
    Thyroid. 2019 Jul 31. doi: 10.1089/thy.2018.0385.
    PubMed     Abstract available


  118. VAN TASSELL B, Wohlford GF, Linderman JD, Smith S, et al
    Pharmacokinetics of Liothyronine in Patients Undergoing Thyroid Hormone Therapy Withdrawal.
    Thyroid. 2019 Jul 31. doi: 10.1089/thy.2019.0101.
    PubMed     Abstract available


  119. YOON JH, Lee HS, Kim EK, Moon HJ, et al
    Follow-up strategies for thyroid nodules with benign cytology on US-guided fine needle aspiration: Malignancy rates of management guidelines using US before and after the era of the Bethesda System.
    Thyroid. 2019 Jul 30. doi: 10.1089/thy.2018.0769.
    PubMed     Abstract available


  120. SHI X, Yu PC, Lei BW, Li CW, et al
    The Association between Programmed Death-Ligand 1 Expression and Clinicopathological Characteristics, Structural Recurrence and Biochemical Recurrence/Persistent Disease in Medullary Thyroid Carcinoma.
    Thyroid. 2019 Jul 20. doi: 10.1089/thy.2019.0079.
    PubMed     Abstract available


  121. BARROS-FILHO MC, Dos Reis MB, Beltrami CM, de Mello JBH, et al
    DNA methylation-based method to differentiate malignant from benign thyroid lesions.
    Thyroid. 2019 Jul 20. doi: 10.1089/thy.2018.0458.
    PubMed     Abstract available


  122. WANG JR, Zafereo M, Dadu R, Ferrarotto R, et al
    Complete surgical resection following neoadjuvant dabrafenib plus trametinib in BRAFV600E-mutated anaplastic thyroid carcinoma.
    Thyroid. 2019 Jul 18. doi: 10.1089/thy.2019.0133.
    PubMed     Abstract available


  123. ITO Y, Ishikawa H, Kihara M, Hirokawa M, et al
    Control of lung metastases and colon polyposis with lenvatinib therapy in a patient with cribriform-morular variant of papillary thyroid carcinoma and an APC gene mutation: a case study.
    Thyroid. 2019 Jul 18. doi: 10.1089/thy.2019.0121.
    PubMed     Abstract available


  124. SHOBAB L, Gomes-Lima CJ, Zeymo A, Feldman R, et al
    Clinical, Pathological and Molecular Profiling of Radioactive Iodine Refractory Differentiated Thyroid Cancer.
    Thyroid. 2019 Jul 18. doi: 10.1089/thy.2019.0075.
    PubMed     Abstract available


  125. NIKIFOROV YE, Nikitski AV, Rominski SL, Condello V, et al
    Mouse Model of Thyroid Cancer Progression and Dedifferentiation Driven by STRN-ALK Expression and Loss of p53: Evidence for the Existence of Two Types of Poorly Differentiated Carcinoma.
    Thyroid. 2019 Jul 12. doi: 10.1089/thy.2019.0284.
    PubMed     Abstract available


  126. CHERELLA CE, Angell TE, Richman DM, Frates MC, et al
    Differences in Thyroid Nodule Cytology and Malignancy Risk between Children and Adults.
    Thyroid. 2019 Jul 12. doi: 10.1089/thy.2018.0728.
    PubMed     Abstract available


  127. TANAKA A, Matsuse M, Saenko VA, Nakao T, et al
    TERT mRNA expression as a novel prognostic marker in papillary thyroid carcinomas.
    Thyroid. 2019 Jul 9. doi: 10.1089/thy.2018.0695.
    PubMed     Abstract available


    June 2019
  128. SIGAL GA, Tavoni T, Silva B, Kalil Filho R, et al
    Response to Dullaart et al., "paper by Sigal GA et al, Thyroid 2019".
    Thyroid. 2019 Jun 25. doi: 10.1089/thy.2019.0384.
    PubMed     Abstract available


  129. PAPALEONTIOU M, Reyes-Gastelum D, Gay BL, Ward KC, et al
    Worry in Thyroid Cancer Survivors with A Favorable Prognosis.
    Thyroid. 2019 Jun 22. doi: 10.1089/thy.2019.0163.
    PubMed     Abstract available


  130. VAN NOSTRAND D
    Radioiodine Imaging for Differentiated Thyroid Cancer: Not All Radioiodine Images are Performed Equally.
    Thyroid. 2019 Jun 11. doi: 10.1089/thy.2018.0690.
    PubMed     Abstract available


  131. KONG SH, Ryu J, Kim MJ, Cho SW, et al
    Longitudinal Assessment of Quality of Life According to Treatment Options in Low Risk Papillary Thyroid Microcarcinoma Patients - Active Surveillance or Immediate Surgery (Interim Analysis of MAeSTro).
    Thyroid. 2019 Jun 4. doi: 10.1089/thy.2018.0624.
    PubMed     Abstract available


  132. ENDO M, Nabhan F, Porter K, Roll K, et al
    Afirma Gene Sequencing Classifier compared to Gene Expression Classifier in Indeterminate Thyroid Nodules.
    Thyroid. 2019 Jun 1. doi: 10.1089/thy.2018.0733.
    PubMed     Abstract available


    May 2019
  133. ABU-HELALAH M, Alshraideh HA, Al-Sarayreh SA, Al Shawabkeh AH, et al
    A cross-sectional study to assess the prevalence of adult Hypothyroidism and hyperthyroidism in Jordan.
    Thyroid. 2019 May 31. doi: 10.1089/thy.2018.0579.
    PubMed     Abstract available


  134. VAN VELSEN EFS, Stegenga M, van Kemenade FJ, Kam B, et al
    Evaluating the 2015 American Thyroid Association Risk Stratification System in High Risk Papillary and Follicular Thyroid Cancer Patients.
    Thyroid. 2019 May 29. doi: 10.1089/thy.2019.0053.
    PubMed     Abstract available


  135. IZKHAKOV E, Vaisman N, Barnes S, Barchana M, et al
    Body composition, resting energy expenditure and metabolic changes in women diagnosed with differentiated thyroid carcinoma.
    Thyroid. 2019 May 15. doi: 10.1089/thy.2018.0483.
    PubMed     Abstract available


  136. UCAL Y, Tokat F, Duren M, Ince U, et al
    Peptide Profile Differences of Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features, Encapsulated Follicular Variant, and Classical Papillary Thyroid Carcinoma: An Application of MALDI Mass Spectrometry Imaging.
    Thyroid. 2019 May 8. doi: 10.1089/thy.2018.0392.
    PubMed     Abstract available


  137. EDO N, Kawakami K, Fujita Y, Morita K, et al
    Exosomes expressing thyrotropin receptor ameliorate autoantibody-mediated stimulation of cyclic adenosine monophosphate production.
    Thyroid. 2019 May 7. doi: 10.1089/thy.2018.0772.
    PubMed     Abstract available


  138. KOREVAAR T, Haymart MR
    A History of Thyroid Cancer Does Not Meaningfully Complicate Pregnancy.
    Thyroid. 2019 May 2. doi: 10.1089/thy.2019.0276.
    PubMed     Abstract available


  139. DUSKIN-BITAN H, Leibner A, Amitai O, Diker-Cohen T, et al
    Bone-Marrow Suppression in Elderly Patients Following Empiric Radioiodine Therapy: Real-Life Data.
    Thyroid. 2019;29:683-691.
    PubMed     Abstract available


    April 2019
  140. JEON M, Lee YM, Sung TY, Han M, et al
    Quality of life in patients with papillary thyroid microcarcinoma managed by active surveillance or lobectomy : A cross-sectional study.
    Thyroid. 2019 Apr 30. doi: 10.1089/thy.2018.0711.
    PubMed     Abstract available


  141. KIM HI, Hyeon J, Park SY, Ahn HS, et al
    Impact of extranodal extension on risk stratification in papillary thyroid carcinoma.
    Thyroid. 2019 Apr 26. doi: 10.1089/thy.2018.0541.
    PubMed     Abstract available


  142. WU D, Gomes Lima CJ, Moreau SL, Kulkarni K, et al
    Improved survival after multimodal approach with 131I treatment in patients with bone metastasis secondary to differentiated thyroid cancer.
    Thyroid. 2019 Apr 24. doi: 10.1089/thy.2018.0582.
    PubMed     Abstract available


  143. STRICKAERT A, Corbet C, Spinette SA, Craciun L, et al
    Reprogramming of energetic metabolism: increased expression and roles of pyruvate carboxylase in papillary thyroid cancer.
    Thyroid. 2019 Apr 16. doi: 10.1089/thy.2018.0435.
    PubMed     Abstract available


  144. CHO GJ, Kim SY, Lee HC, Lee KM, et al
    The risk of adverse obstetric outcomes and the abnormal growth of offspring in women with a history of thyroid cancer.
    Thyroid. 2019 Apr 8. doi: 10.1089/thy.2018.0283.
    PubMed     Abstract available


  145. WANG Y, Liyanarachchi S, Miller KE, Nieminen TT, et al
    Identification of rare variants predisposing to thyroid cancer.
    Thyroid. 2019 Apr 8. doi: 10.1089/thy.2018.0736.
    PubMed     Abstract available


  146. SCHURCH CM, Roelli MA, Forster S, Wasmer MH, et al
    Targeting CD47 in anaplastic thyroid carcinoma enhances tumor phagocytosis by macrophages and is a promising therapeutic strategy.
    Thyroid. 2019 Apr 2. doi: 10.1089/thy.2018.0555.
    PubMed     Abstract available


    March 2019
  147. JOO LJS, Weiss J, Gill AJ, Clifton-Bligh RJ, et al
    RET kinase-regulated microRNA-153-3p improves therapeutic efficacy in medullary thyroid carcinoma.
    Thyroid. 2019 Mar 30. doi: 10.1089/thy.2018.0525.
    PubMed     Abstract available


  148. OTSUBO R, Matsuda K, Mussazhanova Z, Sato A, et al
    A novel diagnostic method for thyroid follicular tumors based on immunofluorescence analysis of p53-binding protein 1 expression: detection of genomic instability.
    Thyroid. 2019 Mar 30. doi: 10.1089/thy.2018.0548.
    PubMed     Abstract available


  149. DONG W, Horiuchi K, Tokumitsu H, Sakamoto A, et al
    Time-varying Pattern of Mortality and Recurrence from Papillary Thyroid Cancer: Lessons from a Long-Term Follow-Up.
    Thyroid. 2019 Mar 30. doi: 10.1089/thy.2018.0128.
    PubMed     Abstract available


  150. ZHANG B, Tian J, Pei S, Chen Y, et al
    Machine Learning-Assisted System for Thyroid Nodule Diagnosis.
    Thyroid. 2019 Mar 30. doi: 10.1089/thy.2018.0380.
    PubMed     Abstract available


  151. CAO X, Dang L, Zheng X, Lu Y, et al
    Targeting super-enhancer-driven oncogenic transcription by CDK7 inhibition in anaplastic thyroid cancer.
    Thyroid. 2019 Mar 29. doi: 10.1089/thy.2018.0550.
    PubMed     Abstract available


  152. TURK A, Asa SL, Baloch ZW, Faquin WC, et al
    Interobserver Variability in the Histopathologic Assessment of Extrathyroidal Extension of Well Differentiated Thyroid Carcinoma Supports the New AJCC 8th Edition Criteria for Tumor Staging.
    Thyroid. 2019 Mar 27. doi: 10.1089/thy.2018.0286.
    PubMed     Abstract available


  153. TUTTLE RM MD, Ahuja S, Avram AM, Bernet V, et al
    Controversies, Consensus and Collaboration in the Use of I-131 Therapy in Differentiated Thyroid Cancer.
    Thyroid. 2019 Mar 22. doi: 10.1089/thy.2018.0597.
    PubMed     Abstract available


  154. CAMPENNI A, Trimboli P, Giovanella L
    99mTc-MIBI scan in patients with thyroid nodules: not for everyone but....
    Thyroid. 2019 Mar 20. doi: 10.1089/thy.2018.0712.
    PubMed     Abstract available


  155. HURTADO-LOPEZ LM, Duncker CM
    The use of Tc-99m-Methoxy-Isobutyl-Isonitrile (MIBI) for differentiation of malignant thyroid nodules.
    Thyroid. 2019 Mar 20. doi: 10.1089/thy.2018.0757.
    PubMed     Abstract available


  156. DULLAART RPF
    response letter to paper by Sigal GA et al; Thyroid doi: 10.1089/thy.2018.0190. [Epub ahead of print].
    Thyroid. 2019 Mar 19. doi: 10.1089/thy.2019.0024.
    PubMed     Abstract available


  157. LEBOULLEUX S, Dupuy C, Lacroix L, Attard M, et al
    Redifferentiation of a BRAF-K601E mutated poorly differentiated thyroid cancer patient with dabrafenib and trametinib treatment.
    Thyroid. 2019 Mar 18. doi: 10.1089/thy.2018.0457.
    PubMed     Abstract available


  158. JEONG JH, Oh JM, Jeong SY, Lee SW, et al
    Combination treatment with BRAFV600E inhibitor, vemurafenib, and BH3 mimetic, navitoclax, for BRAF mutant thyroid carcinoma.
    Thyroid. 2019 Mar 14. doi: 10.1089/thy.2018.0511.
    PubMed     Abstract available


  159. WONG KS, Lorch J, Alexander EK, Nehs MA, et al
    Clinicopathologic Features of Mismatch Repair-Deficient Anaplastic Thyroid Carcinomas.
    Thyroid. 2019 Mar 14. doi: 10.1089/thy.2018.0716.
    PubMed     Abstract available


  160. AHN J, Song E, Oh HS, Song DE, et al
    Low lymphocyte-to-monocyte ratios are associated with poor overall survival in anaplastic thyroid carcinoma patients.
    Thyroid. 2019 Mar 13. doi: 10.1089/thy.2018.0684.
    PubMed     Abstract available


  161. OH HS, Kwon H, Song E, Jeon M, et al
    Tumor Volume Doubling Time in Active Surveillance of Papillary Thyroid Carcinoma.
    Thyroid. 2019 Mar 13. doi: 10.1089/thy.2018.0609.
    PubMed     Abstract available


  162. PICCARDO A, Trimboli P, Puntoni M, Foppiani L, et al
    Role of 18F-FCH PET/CT to detect structural relapse in high risk Differentiated Thyroid Cancer patients.
    Thyroid. 2019 Mar 13. doi: 10.1089/thy.2018.0552.
    PubMed     Abstract available


  163. YAISH I, Azem F, Tordjman KM
    Re: "Effects of Radioactive Iodine Therapy on Ovarian Reserve: A Prospective Pilot Study" by Evranos et al. (Thyroid 2018;28:1702-1707).
    Thyroid. 2019;29:453.
    PubMed    


    February 2019
  164. MAURI G, Pacella CM, Papini E, Solbiati L, et al
    Image-guided Thyroid Ablation: Proposal for Standardization of Terminology and Reporting Criteria.
    Thyroid. 2019 Feb 26. doi: 10.1089/thy.2018.0604.
    PubMed     Abstract available


  165. ANGELL TE, Heller HT, Cibas E, Barletta J, et al
    An independent comparison of the Afirma genomic sequencing classifier (GSC) and gene expression classifier (GEC) for cytologically indeterminate thyroid nodules.
    Thyroid. 2019 Feb 26. doi: 10.1089/thy.2018.0726.
    PubMed     Abstract available


  166. GERON Y, Benbassat C, Steinschneider M, Or K, et al
    Multifocality is not an Independent Prognostic Factor in Papillary Thyroid Cancer: A Propensity Score Matching Analysis.
    Thyroid. 2019 Feb 23. doi: 10.1089/thy.2018.0547.
    PubMed     Abstract available


  167. SHIRAIWA K, Matsuse M, Nakazawa Y, Ogi T, et al
    The JAK/STAT3 and NF-kappaB signaling pathways regulate cancer stem cell properties in anaplastic thyroid cancer cells.
    Thyroid. 2019 Feb 20. doi: 10.1089/thy.2018.0212.
    PubMed     Abstract available


  168. IBRAHIMPASIC T, Ghossein R MD, Shah JP, Ganly I, et al
    Poorly differentiated carcinoma of the thyroid gland: Current status and future prospects.
    Thyroid. 2019 Feb 12. doi: 10.1089/thy.2018.0509.
    PubMed     Abstract available


  169. GENUTIS LK, Tomsic J, Bundschuh R, Brock P, et al
    Microsatellite Instability Occurs in a Subset of Follicular Thyroid Cancers.
    Thyroid. 2019 Feb 12. doi: 10.1089/thy.2018.0655.
    PubMed     Abstract available


  170. TING J, Bell D, Ahmed S, Ying A, et al
    Primary Malignant Thyroid Teratoma: An Institutional Experience.
    Thyroid. 2019;29:229-236.
    PubMed     Abstract available


    January 2019
  171. RAHMAN S, McLeod DSA, Pandeya N, Neale RE, et al
    Understanding pathways to the diagnosis of thyroid cancer - are there ways we can reduce over-diagnosis?
    Thyroid. 2019 Jan 31. doi: 10.1089/thy.2018.0570.
    PubMed     Abstract available


  172. OLLERO MD, Toni M, Pineda JJ, Martinez JP, et al
    Thyroid function reference values in healthy iodine-sufficient pregnant women and influence of thyroid nodules on thyroid-stimulating hormone and free thyroxine values.
    Thyroid. 2019 Jan 29. doi: 10.1089/thy.2018.0324.
    PubMed     Abstract available


  173. HURST Z, Liyanarachchi S, He H, Brock P, et al
    Risk Haplotypes Uniquely Associated with Radioiodine Refractory Thyroid Cancer Patients of High African Ancestry.
    Thyroid. 2019 Jan 18. doi: 10.1089/thy.2018.0687.
    PubMed     Abstract available


  174. NIKIFOROVA MN, Nikitski AV, Panebianco F, Kaya C, et al
    GLIS Rearrangement is a Genomic Hallmark of Hyalinizing Trabecular Tumor of the Thyroid Gland.
    Thyroid. 2019 Jan 16. doi: 10.1089/thy.2018.0791.
    PubMed     Abstract available


  175. KWON H, Chang Y, Cho A, Ahn J, et al
    Metabolic Obesity Phenotypes and Thyroid Cancer Risk: A Cohort Study.
    Thyroid. 2019 Jan 16. doi: 10.1089/thy.2018.0327.
    PubMed     Abstract available


  176. MATHIESEN JS, Kroustrup JP, Vestergaard P, Poulsen PL, et al
    Survival and long-term biochemical cure in medullary thyroid carcinoma in Denmark 1997-2014: A nationwide study.
    Thyroid. 2019 Jan 8. doi: 10.1089/thy.2018.0564.
    PubMed     Abstract available


  177. HILL KA, Yip L, Carty SE, McCoy KL, et al
    Concomitant thyroid cancer in patients with Multiple Endocrine Neoplasia (MEN)-1 undergoing surgery for primary hyperparathyroidism.
    Thyroid. 2019 Jan 4. doi: 10.1089/thy.2017.0675.
    PubMed     Abstract available


    December 2018
  178. HE X, Wu D, Hu C, Xu T, et al
    Role of Metformin in the Treatment of Patients with Thyroid Nodules and Insulin Resistance: A Systematic Review and Meta- Analysis.
    Thyroid. 2018 Dec 29. doi: 10.1089/thy.2017.0707.
    PubMed     Abstract available


  179. SAKAI T, Sugitani I, Ebina A, Fukuoka O, et al
    Active surveillance for T1bN0M0 papillary thyroid carcinoma.
    Thyroid. 2018 Dec 18. doi: 10.1089/thy.2018.0462.
    PubMed     Abstract available


  180. JIN Y, Ruan M, Cheng L, Fu H, et al
    Radioiodine Uptake and Thyroglobulin Guided Radioiodine Remnant Ablation in Patients with Differentiated Thyroid Cancer: A Prospective, Randomized, Open-label, Controlled Trial.
    Thyroid. 2018 Dec 18. doi: 10.1089/thy.2018.0028.
    PubMed     Abstract available


  181. NA W, Li Y, Wei J, Pu J, et al
    TBX1 functions as a tumor suppressor in thyroid cancer through inhibiting the activities of PI3K/AKT and MAPK/ERK pathways.
    Thyroid. 2018 Dec 13. doi: 10.1089/thy.2018.0312.
    PubMed     Abstract available


  182. COLOMBO C, Muzza M, Proverbio MC, Tosi D, et al
    IMPACT OF MUTATION DENSITY AND HETEROGENEITY ON PAPILLARY THYROID CANCER CLINICAL FEATURES AND REMISSION PROBABILITY.
    Thyroid. 2018 Dec 1. doi: 10.1089/thy.2018.0339.
    PubMed     Abstract available


    November 2018
  183. LUSTER M, Aktolun C, Amendoeira I, Barczynski M, et al
    European perspective on the 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Proceedings of an interactive international symposium.
    Thyroid. 2018 Nov 28. doi: 10.1089/thy.2017.0129.
    PubMed     Abstract available


  184. BONGIOVANNI M, Giovanella L, Romanelli F, Trimboli P, et al
    Cytological diagnoses associated with non-invasive follicular thyroid neoplasms with papillary-like nuclear features, (NIFTP) according to the Bethesda System for Reporting Thyroid Cytopathology: a systematic review and meta-analysis.
    Thyroid. 2018 Nov 14. doi: 10.1089/thy.2018.0394.
    PubMed     Abstract available


  185. KIM M, Jeon M, Han M, Lee JH, et al
    Tumor growth rate does not predict malignancy in surgically resected thyroid nodules classified as Bethesda category III with architectural atypia.
    Thyroid. 2018 Nov 13. doi: 10.1089/thy.2018.0366.
    PubMed     Abstract available


  186. SIGAL GA, Tavoni T, Silva B, Kalil Filho R, et al
    Effects of short term hypothyroidism on the lipid transfer to HDL and other parameters related to lipoprotein metabolism in patients submitted to thyroidectomy for thyroid cancer.
    Thyroid. 2018 Nov 9. doi: 10.1089/thy.2018.0190.
    PubMed     Abstract available


  187. BOUFRAQECH M, Patel D, Nilubol N, Powers AS, et al
    Lysyl Oxidase is a key player in BRAF/MAPK pathway-driven thyroid cancer aggressiveness.
    Thyroid. 2018 Nov 6. doi: 10.1089/thy.2018.0424.
    PubMed     Abstract available


  188. OH HS, Ahn J, Song E, Han JM, et al
    Individualized Follow-up Strategy for Patients with Indeterminate Response to Initial Therapy for Papillary Thyroid Carcinoma.
    Thyroid. 2018 Nov 1. doi: 10.1089/thy.2018.0391.
    PubMed     Abstract available


    October 2018
  189. SONG E, Han M, Oh HS, Kim WW, et al
    Lobectomy is feasible for papillary thyroid carcinomas sized 1-4 cm: A 10-year propensity score matched pair analysis on recurrence.
    Thyroid. 2018 Oct 30. doi: 10.1089/thy.2018.0554.
    PubMed     Abstract available


  190. YU CY, Saeed O, Goldberg AS, Farooq S, et al
    A Systematic Review and Meta-analysis of Subsequent Malignant Neoplasm Risk after Radioactive Iodine Treatment of Thyroid Cancer.
    Thyroid. 2018 Oct 27. doi: 10.1089/thy.2018.0244.
    PubMed     Abstract available


  191. SONG E, Lee YM, Oh HS, Jeon M, et al
    A relook at the T stage of differentiated thyroid carcinoma: focus on gross extrathyroidal extension.
    Thyroid. 2018 Oct 25. doi: 10.1089/thy.2018.0300.
    PubMed     Abstract available


  192. LI P, Zhang A, Liu Y, Xu C, et al
    131I Therapy in Patients with Differentiated Thyroid Cancer: Study of External Dose Rate Attenuation Law and Individualized Patient Management.
    Thyroid. 2018 Oct 23. doi: 10.1089/thy.2017.0570.
    PubMed     Abstract available


  193. DEKKER B, van der Horst-Schrivers ANA, Sluiter WJ, Brouwers AH, et al
    The clinical applicability of low levels of thyroglobulin autoantibodies (TgAbs) as cut-off point for TgAb positivity.
    Thyroid. 2018 Oct 23. doi: 10.1089/thy.2018.0195.
    PubMed     Abstract available


  194. SANTOS MT, Buzolin AL, Gama RR, Silva ECA, et al
    Molecular classification of thyroid nodules with indeterminate cytology: development and validation of a highly sensitive and specific new miRNA-based classifier test using fine-needle aspiration smear slides.
    Thyroid. 2018 Oct 15. doi: 10.1089/thy.2018.0254.
    PubMed     Abstract available


  195. HA EJ, Na DG, Moon WJ, Lee Y, et al
    Diagnostic Performance of Ultrasound-based Risk Stratification Systems for Thyroid Nodules: Comparison of the 2015 ATA guidelines with the 2016 KTA/KSThR and 2017 ACR guidelines.
    Thyroid. 2018 Oct 12. doi: 10.1089/thy.2018.0094.
    PubMed     Abstract available


  196. MCIVER B, Freeman JL, Shah JP, Shaha AR MD, et al
    Summary of the third World Congress on Thyroid Cancer.
    Thyroid. 2018 Oct 10. doi: 10.1089/thy.2018.0616.
    PubMed     Abstract available


  197. CIPRIANI NA, White MG, Angelos P, Grogan RH, et al
    Large Cytologically Benign Thyroid Nodules Do Not Have High Rates of Malignancy or False-Negative Rates and Clinical Observation Should be Considered: A Meta-Analysis.
    Thyroid. 2018 Oct 3. doi: 10.1089/thy.2018.0221.
    PubMed     Abstract available


    September 2018
  198. HEDMAN C, Djarv T, Strang P, Lundgren CI, et al
    Fear of recurrence and view of life affect health-related quality of life in patients with differentiated thyroid carcinoma: a prospective Swedish population-based study.
    Thyroid. 2018 Sep 22. doi: 10.1089/thy.2018.0388.
    PubMed     Abstract available


  199. YU C, Zhang L, Luo D, Yan F, et al
    MicroRNA-146b-3p promotes cell metastasis by directly targeting NF2 in human papillary thyroid cancer.
    Thyroid. 2018 Sep 22. doi: 10.1089/thy.2017.0626.
    PubMed     Abstract available


  200. STANG M, Yip L, Eichorn-Wharry L, Bartlett DL, et al
    Gasless Transaxillary Endoscopic Thyroidectomy with Robotic Assistance: a high volume experience in North America.
    Thyroid. 2018 Sep 20. doi: 10.1089/thy.2018.0404.
    PubMed     Abstract available


  201. MAHAJAN P, Dawrant J, Kheradpour A, Quintanilla NM, et al
    Response to Lenvatinib in Children with Papillary Thyroid Carcinoma.
    Thyroid. 2018 Sep 18. doi: 10.1089/thy.2018.0064.
    PubMed     Abstract available


  202. SONG YS, Won JK, Yoo SK, Jung KC, et al
    Comprehensive transcriptomic and genomic profiling of subtypes of follicular variant of papillary thyroid carcinoma.
    Thyroid. 2018 Sep 18. doi: 10.1089/thy.2018.0198.
    PubMed     Abstract available


  203. KIM TM, Kim JH, Yoo RE, Kim SC, et al
    Persistent/Recurrent Differentiated Thyroid Cancer: Clinical and Radiological Characteristics of Persistent Disease and Clinical Recurrence Based on Computed Tomography Analysis.
    Thyroid. 2018 Sep 18. doi: 10.1089/thy.2018.0151.
    PubMed     Abstract available


  204. SIM JS, Baek JH, Cho W
    Initial Ablation Ratio: Quantitative Value Predicting the Therapeutic Success of Thyroid Radiofrequency Ablation.
    Thyroid. 2018 Sep 18. doi: 10.1089/thy.2018.0180.
    PubMed     Abstract available


  205. OH HS, Ha J, Kim HI, Kim TH, et al
    Active Surveillance of Low-Risk Papillary Thyroid Microcarcinoma: A Multi-Center Cohort Study in Korea.
    Thyroid. 2018 Sep 18. doi: 10.1089/thy.2018.0263.
    PubMed     Abstract available


  206. LI Y, Li X, Pu J, Yang Q, et al
    c-Myc is a major determinant for antitumor activity of Aurora A kinase inhibitor MLN8237 in thyroid cancer.
    Thyroid. 2018 Sep 18. doi: 10.1089/thy.2018.0183.
    PubMed     Abstract available


  207. LIN JD, Liou MJ, Hsu HL, Leong KK, et al
    Circulating Epithelial Cell Characterization and Correlation with Remission and Survival in Patients with Thyroid Cancer.
    Thyroid. 2018 Sep 15. doi: 10.1089/thy.2017.0639.
    PubMed     Abstract available


  208. CARR AA, Yen T, Ortiz DI, Hunt BC, et al
    Oncocytic papillary thyroid cancer has similar prognosis to matched classical papillary thyroid cancer controls.
    Thyroid. 2018 Sep 14. doi: 10.1089/thy.2017.0603.
    PubMed     Abstract available


    August 2018
  209. TAM S, Boonsripitayanon M, Amit M, Fellman BM, et al
    Survival in Differentiated Thyroid Cancer: Comparing the AJCC Cancer Staging 7th and 8th editions.
    Thyroid. 2018 Aug 24. doi: 10.1089/thy.2017.0572.
    PubMed     Abstract available


  210. SUN Y, Du F, Gao M, Ji QH, et al
    Anlotinib for the Treatment of Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer.
    Thyroid. 2018 Aug 24. doi: 10.1089/thy.2018.0022.
    PubMed     Abstract available


  211. JAESCHKE H, Undeutsch H, Patyra K, Lof C, et al
    Hyperthyroidism and papillary thyroid carcinoma in thyrotropin receptor D633H mutant mice.
    Thyroid. 2018 Aug 22. doi: 10.1089/thy.2018.0041.
    PubMed     Abstract available


  212. RAGO T, Scutari M, Loiacono V, Tonacchera M, et al
    Patients with indeterminate thyroid nodules at cytology and cancer at histology have a more favourable outcome with respect to patients with suspicious or malignant cytology.
    Thyroid. 2018 Aug 22. doi: 10.1089/thy.2017.0522.
    PubMed     Abstract available


  213. KIM SJ, Lee SW, Jeong SY, Pak K, et al
    Diagnostic Performance of Tc-99m MIBI for Differentiation of Malignant Thyroid Nodules; A Systematic Review and Meta-analysis.
    Thyroid. 2018 Aug 21. doi: 10.1089/thy.2018.0072.
    PubMed     Abstract available


  214. ZANELLA AB, Scheffel RS, Nava CF, Golbert L, et al
    Dynamic Risk Stratification in the Follow-up of Children and Adolescents with Differentiated Thyroid Cancer.
    Thyroid. 2018 Aug 21. doi: 10.1089/thy.2018.0075.
    PubMed     Abstract available


  215. DAVIES L, Haymart MR
    South Korean Thyroid Cancer Trends: Good news and bad.
    Thyroid. 2018 Aug 16. doi: 10.1089/thy.2018.0508.
    PubMed     Abstract available


  216. BORSON-CHAZOT F, Dantony E, Illouz F, Lopez J, et al
    Effect of Buparlisib, a pan-class I PI3K inhibitor, in refractory follicular and poorly differentiated thyroid cancer.
    Thyroid. 2018 Aug 14. doi: 10.1089/thy.2017.0663.
    PubMed     Abstract available


  217. GRANI G, Lamartina L, Biffoni M, Giacomelli L, et al
    Sonographically estimated risks of malignancy for thyroid nodules computed with five standard classification systems: changes over time and their relation to malignancy.
    Thyroid. 2018 Aug 14. doi: 10.1089/thy.2018.0178.
    PubMed     Abstract available


  218. BECKHAM TH, Romesser PB, Groen AH, Sabol C, et al
    Intensity Modulated Radiation Therapy with or without Concurrent Chemotherapy in Non-Anaplastic Thyroid Cancer with Unresectable or Gross Residual Disease.
    Thyroid. 2018 Aug 14. doi: 10.1089/thy.2018.0214.
    PubMed     Abstract available


  219. VAN NOSTRAND D
    Radioiodine Refractory Differentiated Thyroid Cancer: Time to Update the Classifications.
    Thyroid. 2018 Aug 14. doi: 10.1089/thy.2018.0048.
    PubMed     Abstract available


  220. LLAMAS-OLIER A, Cuellar DI, Buitrago G
    Intermediate-Risk Papillary Thyroid Cancer: Risk Factors for Early Recurrence in Patients with Excellent Response to Initial Therapy.
    Thyroid. 2018 Aug 14. doi: 10.1089/thy.2017.0578.
    PubMed     Abstract available


    July 2018
  221. DANIELS GH
    Follicular Thyroid Carcinoma: A Perspective.
    Thyroid. 2018 Jul 24. doi: 10.1089/thy.2018.0306.
    PubMed     Abstract available


  222. BOGDANOVA TI, Saenko VA, Brenner AV, Zurnadzhy LY, et al
    Comparative Histopathologic Analysis of "Radiogenic" and "Sporadic" Papillary Thyroid Carcinoma: Patients Born Before and After the Chernobyl Accident.
    Thyroid. 2018;28:880-890.
    PubMed     Abstract available


    June 2018
  223. MA B, Wei WJ, Xu W, Wang Y, et al
    Surgical confirmation of incomplete treatment for primary papillary thyroid carcinoma by percutaneous thermal ablation: A retrospective case review and literature review.
    Thyroid. 2018 Jun 30. doi: 10.1089/thy.2017.0558.
    PubMed     Abstract available


  224. SCHMIDT JENSEN J, Gronhoj C, Mirian C, Jensen DH, et al
    Incidence and survival of thyroid cancer in children, adolescents, and young adults in Denmark: a nation-wide study from 1980 to 2014.
    Thyroid. 2018 Jun 26. doi: 10.1089/thy.2018.0067.
    PubMed     Abstract available


  225. TAM S, Amit M, Boonsripitayanon M, Busaidy N, et al
    The Effect of Tumor Size and Minimal Extrathyroidal Extension in Patients with Differentiated Thyroid Cancer.
    Thyroid. 2018 Jun 23. doi: 10.1089/thy.2017.0513.
    PubMed     Abstract available


  226. SEMRAD TJ, Keegan T, Semrad AM, Brunson A, et al
    Predictors of Neck Reoperation and Mortality after Initial Total Thyroidectomy for Differentiated Thyroid Cancer.
    Thyroid. 2018 Jun 21. doi: 10.1089/thy.2017.0483.
    PubMed     Abstract available


  227. TRAN BM, Roshan DJ, Abraham E, Wang LY, et al
    The Prognostic Impact of Tumor Size in Papillary Thyroid Carcinoma is Modified by Age.
    Thyroid. 2018 Jun 19. doi: 10.1089/thy.2017.0607.
    PubMed     Abstract available


  228. BRITO JP, Moon JH, Zeuren R, Kong SH, et al
    Thyroid Cancer Treatment Choice: A pilot study of a tool to facilitate conversations with patients with papillary microcarcinomas considering treatment options.
    Thyroid. 2018 Jun 15. doi: 10.1089/thy.2018.0105.
    PubMed     Abstract available


  229. LIANG JY, Huang XW, Hu HT, Liu YH, et al
    <b>Predicting Malignancy in Thyroid Nodules: Radiomics Score versus 2017 American College of Radiology (ACR) Thyroid Imaging, Reporting and Data System (TI-RADS)</b>.
    Thyroid. 2018 Jun 13. doi: 10.1089/thy.2017.0525.
    PubMed     Abstract available


  230. JEON M, Kim HK, Kim EH, Kim ES, et al
    Decreasing Disease-specific Mortality of Differentiated Thyroid Cancer in Korea: A Multicenter Cohort Study.
    Thyroid. 2018 Jun 13. doi: 10.1089/thy.2018.0159.
    PubMed     Abstract available


  231. GHAZNAVI SA, Ganly I, Shaha AR MD, English CL, et al
    Using the ATA risk stratification system to refine and individualize the AJCC 8th edition disease specific survival estimates in differentiated thyroid cancer.
    Thyroid. 2018 Jun 13. doi: 10.1089/thy.2018.0186.
    PubMed     Abstract available


  232. HUK D, Ashtekar A, Magner A, La Perle K, et al
    Deletion of Rap1b, but not Rap1a or Epac1, reduces PKA-mediated thyroid cancer.
    Thyroid. 2018 Jun 8. doi: 10.1089/thy.2017.0528.
    PubMed     Abstract available


  233. HUANG Y, Yu S, Cao S, Yin Y, et al
    MicroRNA-222 promotes invasion and metastasis of papillary thyroid cancer through targeting protein phosphatase 2 regulatory subunit B alpha expression.
    Thyroid. 2018 Jun 8. doi: 10.1089/thy.2017.0665.
    PubMed     Abstract available


  234. MATRONE A, Latrofa F, Torregrossa L, Piaggi P, et al
    Changing trend of thyroglobulin antibodies in not 131I ablated differentiated thyroid cancer patients.
    Thyroid. 2018 Jun 2. doi: 10.1089/thy.2018.0080.
    PubMed     Abstract available


    May 2018
  235. VAN VELSEN EFS, Stegenga M, van Kemenade FJ, Kam B, et al
    Comparing the Prognostic Value of the Eighth Edition of the AJCC/TNM Staging System between Papillary and Follicular Thyroid Cancer.
    Thyroid. 2018 May 31. doi: 10.1089/thy.2018.0066.
    PubMed     Abstract available


  236. VALDERRABANO P, McGettigan MJ, Lam C, Khazai L, et al
    Thyroid nodules with indeterminate cytology: Utility of the American Thyroid Association sonographic patterns for cancer risk stratification.
    Thyroid. 2018 May 31. doi: 10.1089/thy.2018.0085.
    PubMed     Abstract available


  237. PARK S, Jeon M, Oh HS, Lee YM, et al
    Changes in Serum Thyroglobulin Levels after Lobectomy in Patients with Low-Risk Papillary Thyroid Cancer.
    Thyroid. 2018 May 30. doi: 10.1089/thy.2018.0046.
    PubMed     Abstract available


  238. CHO YY, Kang MJ, Kim SK, Jung J, et al
    Protective Effect of Metformin against Thyroid Cancer Development: a Population-based Study in Korea.
    Thyroid. 2018 May 29. doi: 10.1089/thy.2017.0550.
    PubMed     Abstract available


  239. WANG T, Jiang M, Ren Y, Liu Q, et al
    Health-related quality of life of community thyroid cancer survivors in Hangzhou, China.
    Thyroid. 2018 May 29. doi: 10.1089/thy.2017.0213.
    PubMed     Abstract available


  240. OWEIDA AJ, Phan A, Vancourt B, Robin T, et al
    Hypofractionated radiotherapy is superior to conventional fractionation in an orthotopic model of anaplastic thyroid cancer.
    Thyroid. 2018 May 18. doi: 10.1089/thy.2017.0706.
    PubMed     Abstract available


  241. HE H, Li W, Yan P, Bundschuh R, et al
    Identification of a Recurrent LMO7-BRAF Fusion in Papillary Thyroid Carcinoma.
    Thyroid. 2018 May 16. doi: 10.1089/thy.2017.0258.
    PubMed     Abstract available


  242. CHUNG SR, Choi YJ, Suh CH, Kim HJ, et al
    Thyroid incidentalomas detected on 18F-FDG PET/CT: Malignant risk stratification and management plan.
    Thyroid. 2018 May 15. doi: 10.1089/thy.2017.0560.
    PubMed     Abstract available


  243. CHU KP, Baker SP, Zenke JK, Morad A, et al
    Low-Activity Radioactive Iodine Therapy for Thyroid Carcinomas Exhibiting Nodal Metastases and Extrathyroidal Extension May Lead to Early Disease Recurrence.
    Thyroid. 2018 May 10. doi: 10.1089/thy.2017.0136.
    PubMed     Abstract available


  244. CABANILLAS M, Ferrarotto R, Garden A, Ahmed S, et al
    Neoadjuvant BRAF- and immune- directed therapy for anaplastic thyroid carcinoma.
    Thyroid. 2018 May 10. doi: 10.1089/thy.2018.0060.
    PubMed     Abstract available


  245. MOSS W, Finegersh A, Pang J, Califano JA, et al
    Needle biopsy of routine thyroid nodules should be performed using a capillary action technique with 24-27 gauge needles: a systematic review and meta-analysis.
    Thyroid. 2018 May 10. doi: 10.1089/thy.2017.0643.
    PubMed     Abstract available



  246. Correction to: Tertiary Care Experience of Sorafenib in the Treatment of Progressive Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Korean Multicenter Study, by Kim M, Kim TH, Shin DY, Lim DJ, Kim EY, Kim WB, Chung JH, Shong YK, Kim BH, an
    Thyroid. 2018;28:686.
    PubMed    


    April 2018
  247. VERBURG F, Maeder U, Giovanella L, Luster M, et al
    Low or undetectable basal thyroglobulin levels obviate the need for neck ultrasound in differentiated thyroid cancer patients after total thyroidectomy and I-131 ablation.
    Thyroid. 2018 Apr 18. doi: 10.1089/thy.2017.0352.
    PubMed     Abstract available


  248. NABHAN F, Porter K, Lupo M, Randolph GW, et al
    Heterogeneity in PPV of RAS Mutations in Cytologically Indeterminate Thyroid Nodules.
    Thyroid. 2018 Apr 18. doi: 10.1089/thy.2017.0635.
    PubMed     Abstract available


  249. DAVIES L, Sugino K, Sugitani I, Tomoda C, et al
    Response to Magner JA: "High Thyroid Cancer Mortality Rate in Japan: A Result of Non-aggressive Treatment Strategy, or Just an Aging Population?"
    Thyroid. 2018 Apr 12. doi: 10.1089/thy.2018.0203.
    PubMed     Abstract available


  250. BUJ R, Mallona I, Diez-Villanueva A, Zafon C, et al
    Kallikreins stepwise scoring reveals three subtypes of papillary thyroid cancer with prognostic applications.
    Thyroid. 2018 Apr 11. doi: 10.1089/thy.2017.0501.
    PubMed     Abstract available


  251. HUANG P, Mao LF, Zhang ZP, Lv WW, et al
    Down-Regulated miR-125a-5p Promotes the Reprogramming of Glucose Metabolism and Cell Malignancy by Increasing Levels of CD147 in Thyroid Cancer.
    Thyroid. 2018 Apr 10. doi: 10.1089/thy.2017.0401.
    PubMed     Abstract available


  252. SINGH-OSPINA N, Castaneda-Guarderas A, Hamidi O, Ponce OJ, et al
    Weight changes after thyroid surgery for patients with benign thyroid nodules and thyroid cancer: population based study and systematic review and meta-analysis.
    Thyroid. 2018 Apr 10. doi: 10.1089/thy.2017.0216.
    PubMed     Abstract available


  253. MAGNER JA
    High Thyroid Cancer Mortality Rate in Japan: A Result of Nonaggressive Treatment Strategy, or Just an Aging Population?
    Thyroid. 2018 Apr 9. doi: 10.1089/thy.2018.0121.
    PubMed    


  254. KIM M, Jeon MJ, Oh HS, Park S, et al
    Prognostic Implication of N1b Classification in the Eighth Edition of the Tumor-Node-Metastasis Staging System of Differentiated Thyroid Cancer.
    Thyroid. 2018 Apr 5. doi: 10.1089/thy.2017.0473.
    PubMed     Abstract available


  255. WANG Z, Vyas CM, Van Benschoten O, Nehs MA, et al
    Quantitative Analysis of the Benefits and Risk of Thyroid Nodule Evaluation in Patients >/=70 Years Old.
    Thyroid. 2018 Apr 2. doi: 10.1089/thy.2017.0655.
    PubMed     Abstract available


  256. ITO Y, Miyauchi A, Kudo T, Oda H, et al
    Trends in the Implementation of Active Surveillance for Low-Risk Papillary Thyroid Microcarcinomas at Kuma Hospital: Gradual Increase and Heterogeneity in the Acceptance of This New Management Option.
    Thyroid. 2018 Apr 2. doi: 10.1089/thy.2017.0448.
    PubMed     Abstract available


    March 2018
  257. LIM JXY, Nga ME, Chan DKH, Tan WB, et al
    Subclassification of Bethesda Atypical and Follicular Neoplasm Categories According to Nuclear and Architectural Atypia Improves Discrimination of Thyroid Malignancy Risk.
    Thyroid. 2018 Mar 29. doi: 10.1089/thy.2017.0274.
    PubMed     Abstract available


  258. BONGIOVANNI M, Papadakis GE, Rouiller N, Marino L, et al
    The Bethesda System for Reporting Thyroid Cytopathology explained for practitioners: Frequently Asked Questions.
    Thyroid. 2018 Mar 28. doi: 10.1089/thy.2017.0685.
    PubMed     Abstract available


  259. ROSARIO PW
    Re: "A Follow-Up Strategy for Patients with Excellent Response to Initial Therapy for Differentiated Thyroid Carcinoma" by Jeon et al. (Thyroid 2018;28:187-192).
    Thyroid. 2018 Mar 27. doi: 10.1089/thy.2017.0644.
    PubMed    


  260. LEUNG AM, Lubin JH, Schneider AB
    Response to Cuttler et al. Re: ''Low-Dose Childhood Radiation Effectsto the Thyroid Follow a Linear Dose-Response Trend and Persist Even 45+ Years After Exposure''.
    Thyroid. 2018 Mar 26. doi: 10.1089/thy.2018.0185.
    PubMed     Abstract available


  261. MILLER JE, Al-Attar NC, Brown OH, Shaughness GG, et al
    Location and causation of residual lymph node metastasis after surgical treatment of regionally advanced differentiated thyroid cancer.
    Thyroid. 2018 Mar 21. doi: 10.1089/thy.2017.0434.
    PubMed     Abstract available


    February 2018
  262. DOBNIG H, Amrein K
    Monopolar radiofrequency ablation of thyroid nodules: a prospective Austrian single center study.
    Thyroid. 2018 Feb 28. doi: 10.1089/thy.2017.0547.
    PubMed     Abstract available


  263. YAISH I, Azem F, Gutfeld O, Silman Z, et al
    A Single Radioactive Iodine Treatment has a Deleterious Effect on Ovarian Reserve in Women with Thyroid Cancer: Results of a Prospective Pilot Study.
    Thyroid. 2018 Feb 21. doi: 10.1089/thy.2017.0442.
    PubMed     Abstract available


  264. AGHAJANI M, Graham S, McCafferty C, Shaheed CA, et al
    The clinicopathological and prognostic significance of programmed cell death ligand 1 (PD-L1) expression in patients with non-medullary thyroid cancer: a systematic review and meta-analysis.
    Thyroid. 2018 Feb 17. doi: 10.1089/thy.2017.0441.
    PubMed     Abstract available


  265. LEI J, Zhong J, Li Z, Wei T, et al
    A nomogram based on the characteristics of metastatic lymph nodes to predict papillary thyroid carcinoma recurrence.
    Thyroid. 2018 Feb 14. doi: 10.1089/thy.2017.0422.
    PubMed     Abstract available


  266. KIM M, Jeon M, Oh HS, Park S, et al
    <i>BRAF</i> and <i>RAS</i> mutational status in non-invasive follicular thyroid neoplasm with papillary-like nuclear features and invasive subtype of encapsulated follicular variant of papillary thyroid carcinoma in Korea.
    Thyroid. 2018 Feb 14. doi: 10.1089/thy.2017.0382.
    PubMed     Abstract available


  267. NASH SH, Lanier AP, Southworth MB
    Occurrence of endocrine and thyroid cancers among Alaska Native people, 1969-2013.
    Thyroid. 2018 Feb 14. doi: 10.1089/thy.2017.0408.
    PubMed     Abstract available


  268. HIRSCH D, Twito O, Levy S, Bachar G, et al
    Temporal Trends in the Presentation, Treatment, and Outcome of Medullary Thyroid Carcinoma - An Israeli Multicenter Study.
    Thyroid. 2018 Feb 5. doi: 10.1089/thy.2017.0371.
    PubMed     Abstract available


    January 2018
  269. LUBITZ CC, Zhan T, Gunda V, Amin S, et al
    Circulating BRAFV600E levels correlate with treatment in patients with thyroid carcinoma.
    Thyroid. 2018 Jan 29. doi: 10.1089/thy.2017.0322.
    PubMed     Abstract available


  270. JAHANBANI I, Al-Abdallah A, Ali R, Al-Brahim N, et al
    Discriminatory miRNAs for the management of papillary thyroid carcinoma and noninvasive follicular thyroid neoplasms with papillary-like nuclear features.
    Thyroid. 2018 Jan 29. doi: 10.1089/thy.2017.0127.
    PubMed     Abstract available


  271. NGUYEN XV, Roy Choudhury K, Tessler FN, Hoang JK, et al
    Effect of tumor size on risk of metastatic disease and survival for thyroid cancer: Implications for biopsy guidelines.
    Thyroid. 2018 Jan 26. doi: 10.1089/thy.2017.0526.
    PubMed     Abstract available


  272. KIM M, Kim TH, Shin DY, Lim DJ, et al
    Tertiary Care Experience of Sorafenib in the Treatment of Progressive Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Korean Multicenter Study.
    Thyroid. 2018 Jan 19. doi: 10.1089/thy.2017.0356.
    PubMed     Abstract available


  273. OH HS, Kwon H, Song E, Jeon M, et al
    Preoperative Clinical and Sonographic Predictors for Lateral Cervical Lymph Node Metastases in Sporadic Medullary Thyroid Carcinoma.
    Thyroid. 2018 Jan 19. doi: 10.1089/thy.2017.0514.
    PubMed     Abstract available


  274. KIM MJ, Won JK, Jung KC, Kim JH, et al
    Clinical characteristics of subtypes of follicular variant papillary thyroid carcinoma.
    Thyroid. 2018 Jan 17. doi: 10.1089/thy.2016.0671.
    PubMed     Abstract available


  275. CARVALHO M, Rosario PW, Mourao GF, Oliveira LFF, et al
    Clinical impact of detectable antithyroglobulin antibodies below the reference limit (borderline) in patients with papillary thyroid carcinoma with negative serum thyroglobulin and neck ultrasonography after ablation: a prospective study.
    Thyroid. 2018 Jan 12. doi: 10.1089/thy.2017.0350.
    PubMed     Abstract available


    December 2017
  276. YAKUSHINA VD, Lerner LV, Lavrov AV
    Gene fusions in thyroid cancer.
    Thyroid. 2017 Dec 27. doi: 10.1089/thy.2017.0318.
    PubMed     Abstract available


  277. KIM KH, Gu MO, Jung J, Hahm JR, et al
    Efficacy of a home-based exercise program after thyroidectomy for thyroid cancer patients.
    Thyroid. 2017 Dec 19. doi: 10.1089/thy.2017.0277.
    PubMed     Abstract available


  278. STEINSCHNEIDER M, Muallem Kalmovich L, Koren S, Or K, et al
    Reassessment of Differentiated Thyroid Cancer Patients Using the 8th TNM classification System: a comparative study.
    Thyroid. 2017 Dec 19. doi: 10.1089/thy.2017.0265.
    PubMed     Abstract available


    November 2017
  279. TOMODA C, Sugino K, Tanaka T, Ogimi Y, et al
    Globus symptoms in patients undergoing thyroidectomy: Relationships with psychogenic factors, thyroid disease, and surgical procedure.
    Thyroid. 2017 Nov 28. doi: 10.1089/thy.2017.0524.
    PubMed     Abstract available


  280. JEON M, Kim M, Park S, Oh HS, et al
    A follow-up strategy for patients with excellent response to initial therapy for differentiated thyroid carcinoma : less is better.
    Thyroid. 2017 Nov 27. doi: 10.1089/thy.2017.0130.
    PubMed     Abstract available


  281. WATUTANTRIGE-FERNANDO S, Vianello F, Barollo S, Bertazza L, et al
    The Hobnail variant of Papillary Thyroid Carcinoma: clinical/molecular characteristics of a large monocentric series and comparison with conventional histotypes.
    Thyroid. 2017 Nov 27. doi: 10.1089/thy.2017.0248.
    PubMed     Abstract available


  282. JEON M, Kim YN, Sung TY, Hong SJ, et al
    Practical initial risk stratification based on lymph node metastases in pediatric and adolescent differentiated thyroid cancer.
    Thyroid. 2017 Nov 27. doi: 10.1089/thy.2017.0214.
    PubMed     Abstract available


  283. IYER P, Dadu R, Ferrarotto R, Busaidy N, et al
    Real world experience with targeted therapy for the treatment of anaplastic thyroid carcinoma.
    Thyroid. 2017 Nov 22. doi: 10.1089/thy.2017.0285.
    PubMed     Abstract available


  284. CHEN AJ, Livhits MJ, Du L, Wu JX, et al
    Recent Pregnancy is Not Associated with High-Risk Pathological Features of Well-Differentiated Thyroid Cancer.
    Thyroid. 2017 Nov 21. doi: 10.1089/thy.2017.0496.
    PubMed     Abstract available


  285. HAN MA, Kim JH
    Diagnostic x-ray exposure and thyroid cancer risk: systematic review and meta-analysis.
    Thyroid. 2017 Nov 21. doi: 10.1089/thy.2017.0159.
    PubMed     Abstract available


  286. VALDERRABANO P, Khazai L, Thompson ZJ, Sharpe SC, et al
    Cancer risk associated with nuclear atypia in cytologically indeterminate thyroid nodules. A systematic review and meta-analysis.
    Thyroid. 2017 Nov 21. doi: 10.1089/thy.2017.0419.
    PubMed     Abstract available


  287. KLEIN HESSELINK MS, Bocca G, Hummel YM, Brouwers AH, et al
    Diastolic dysfunction is common in survivors of pediatric differentiated thyroid carcinoma.
    Thyroid. 2017 Nov 13. doi: 10.1089/thy.2017.0383.
    PubMed     Abstract available


  288. GOMES-LIMA CJ, Wu D, Kharazi PH, Khorjekar G, et al
    Selected Radiation Safety Aspects including Transportation and Lodging after Outpatient <sup>131</sup>I Therapy for Differentiated Thyroid Cancer.
    Thyroid. 2017 Nov 13. doi: 10.1089/thy.2017.0124.
    PubMed     Abstract available


  289. CUTTLER J, Mortazavi S, Welsh J, Doss M, et al
    Comments on "Low-Dose Childhood Radiation Effects to the Thyroid Follow a Linear Dose-Response Trend and Persist Even 45+ Years after Exposure".
    Thyroid. 2017 Nov 13. doi: 10.1089/thy.2017.0377.
    PubMed     Abstract available


  290. NAM SH, Roh JL, Gong G, Cho KJ, et al
    Nodal Factors Predictive of Recurrence After Thyroidectomy and Neck Dissection for Papillary Thyroid Carcinoma.
    Thyroid. 2017 Nov 8. doi: 10.1089/thy.2017.0334.
    PubMed     Abstract available


  291. KUO EJ, Thi WJ, Zheng F, Zanocco K, et al
    Individualizing surgery in papillary thyroid carcinoma based on a detailed sonographic assessment of extrathyroidal extension.
    Thyroid. 2017 Nov 7. doi: 10.1089/thy.2017.0457.
    PubMed     Abstract available


  292. HA SM, Ahn HS, Baek JH, Ahn HY, et al
    Validation of Three Scoring Risk Stratification Models for Thyroid Nodules.
    Thyroid. 2017 Nov 6. doi: 10.1089/thy.2017.0363.
    PubMed     Abstract available


  293. MOSTOUFI-MOAB S, Labourier E, Sullivan L, LiVolsi VA, et al
    Molecular Testing for Oncogenic Gene Alterations in Pediatric Thyroid Lesions.
    Thyroid. 2017 Nov 6. doi: 10.1089/thy.2017.0059.
    PubMed     Abstract available


  294. VALENCIAGA A, Grubbs EG, Porter K, Wakely PE Jr, et al
    REDUCED RETINOBLASTOMA PROTEIN EXPRESSION IS ASSOCIATED WITH DECREASED PATIENT SURVIVAL IN MEDULLARY THYROID CANCER.
    Thyroid. 2017 Nov 4. doi: 10.1089/thy.2017.0113.
    PubMed     Abstract available


  295. CIBAS ES, Ali SZ
    The 2017 Bethesda System for Reporting Thyroid Cytopathology.
    Thyroid. 2017;27:1341-1346.
    PubMed     Abstract available


    October 2017
  296. SCHMOHL KA, Dolp P, Schug C, Knoop K, et al
    Reintroducing the sodium iodide symporter (NIS) to anaplastic thyroid carcinoma.
    Thyroid. 2017 Oct 15. doi: 10.1089/thy.2017.0290.
    PubMed     Abstract available


  297. LAMARTINA L, Durante C, Lucisano G, Grani G, et al
    Are evidence-based guidelines reflected in clinical practice? An analysis of prospectively collected data of the Italian Thyroid Cancer Observatory (ITCO#1).
    Thyroid. 2017 Oct 12. doi: 10.1089/thy.2017.0299.
    PubMed     Abstract available


  298. HERNANDEZ-PRERA J, Machado R, Asa SL, Baloch ZW, et al
    Pathologic reporting of Tall Cell Variant of Papillary Thyroid Cancer: Have we reached a consensus?
    Thyroid. 2017 Oct 12. doi: 10.1089/thy.2017.0280.
    PubMed     Abstract available


  299. BARDET S, Ciappuccini R, Pellot-Barakat C, Monpeyssen H, et al
    Shear wave elastography in thyroid nodules with indeterminate cytology: Results of a prospective bicentric study.
    Thyroid. 2017 Oct 6. doi: 10.1089/thy.2017.0293.
    PubMed     Abstract available


  300. AYUBI E, Sullman MJM, Safiri S
    Dynamic Risk Stratification for Predicting Recurrence in Patients with Differentiated Thyroid Cancer Treated Without Radioactive Iodine Remnant Ablation Therapy: Comment on Data Sparsity.
    Thyroid. 2017 Oct 1. doi: 10.1089/thy.2017.0303.
    PubMed     Abstract available


    September 2017
  301. YAMASHITA S
    Lessons from Fukushima: Latest Findings of Thyroid Cancer after the Fukushima Nuclear Power Plant Accident.
    Thyroid. 2017 Sep 27. doi: 10.1089/thy.2017.0283.
    PubMed     Abstract available


  302. HA EJ, Baek JH, Na DG
    Risk Stratification of Thyroid Nodules on Ultrasonography: Current Status and Perspectives.
    Thyroid. 2017 Sep 25. doi: 10.1089/thy.2016.0654.
    PubMed     Abstract available


  303. CANO JM, Galan R, Lopez R
    Recurrent Metastatic Medullary Thyroid Carcinoma: A Case of Sustained Response to Prolonged Treatment with Somatostatin Analogues.
    Thyroid. 2017.
    PubMed     Abstract available


  304. LEE SI, Kim DK, Seo EJ, Choi EJ, et al
    Role of Kruppel-like Factor 4 in the Maintenance of Chemoresistance of Anaplastic Thyroid Cancer.
    Thyroid. 2017.
    PubMed     Abstract available


  305. YAPA S, Mulla O, Green V, England J, et al
    The Role of Chemokines in Thyroid Carcinoma.
    Thyroid. 2017 Sep 11. doi: 10.1089/thy.2016.0660.
    PubMed     Abstract available


  306. RUIZ-FERRER M, Fernandez RM, Navarro E, Antinolo G, et al
    <i>ESR2</i> gene and Medullary Thyroid Carcinoma.
    Thyroid. 2017 Sep 11. doi: 10.1089/thy.2017.0171.
    PubMed     Abstract available


  307. PONTIUS LN, Oyekunle TO, Thomas S, Stang M, et al
    Projecting Survival in Papillary Thyroid Cancer: A Comparison of the 7th and 8th Editions of the AJCC/UICC Staging Systems in Two Contemporary National Patient Cohorts.
    Thyroid. 2017 Sep 11. doi: 10.1089/thy.2017.0306.
    PubMed     Abstract available


  308. HEDMAN C, Strang P, Djarv T, Widberg I, et al
    Anxiety and fear of recurrence despite a good prognosis: an interview study with differentiated thyroid cancer patients.
    Thyroid. 2017 Sep 6. doi: 10.1089/thy.2017.0346.
    PubMed     Abstract available


    August 2017
  309. SAHLI ZT, Umbricht CB, Schneider EB, Zeiger MA Md, et al
    Thyroid Nodule Diagnostic Markers in the Face of the New Diagnosis, NIFT-P: Time for a Reset?
    Thyroid. 2017 Aug 31. doi: 10.1089/thy.2017.0238.
    PubMed     Abstract available


  310. HALL S, Irish JC, Groome PA, Griffiths R, et al
    Do lower risk thyroid cancer patients who live in regions with more aggressive treatments have better outcomes?
    Thyroid. 2017 Aug 29. doi: 10.1089/thy.2017.0103.
    PubMed     Abstract available


  311. SUNG TY, Cho JW, Lee YM, Lee YH, et al
    Dynamic Risk Stratification in Stage I Papillary Thyroid Cancer Patients Younger than 45 Years.
    Thyroid. 2017 Aug 28. doi: 10.1089/thy.2017.0199.
    PubMed     Abstract available


  312. CHINN SB, Zafereo M, Waguespack SG, Edeiken BS, et al
    Long-term outcomes of lateral neck dissection in patients with recurrent or persistent well-differentiated thyroid cancer.
    Thyroid. 2017 Aug 15. doi: 10.1089/thy.2017.0203.
    PubMed     Abstract available


  313. VALDERRABANO P, Khazai L, Thompson ZJ, Leon ME, et al
    Cancer risk stratification of indeterminate thyroid nodules: A cytological approach.
    Thyroid. 2017 Aug 15. doi: 10.1089/thy.2017.0221.
    PubMed     Abstract available


  314. GRANI G, Bruno R, Lucisano G, Costante G, et al
    Temporal changes in thyroid nodule volume: lack of effect on paranodular thyroid tissue volume.
    Thyroid. 2017 Aug 15. doi: 10.1089/thy.2017.0201.
    PubMed     Abstract available


  315. WHITE PS, Pudusseri A, Lee SL, Eton O, et al
    Intermittent Dosing of Dabrafenib and Trametinib in Metastatic BRAFV600E Mutated Papillary Thyroid Cancer: Two Case Reports.
    Thyroid. 2017 Aug 12. doi: 10.1089/thy.2017.0106.
    PubMed     Abstract available


  316. RUHLMANN M, Ruhlmann J, Gorges R, Herrmann K, et al
    18F-FDG PET/CT may exclude malignancy in sonographically suspicious and scintigraphically hypofunctional thyroid nodules and reduce unnecessary thyroid surgeries.
    Thyroid. 2017 Aug 10. doi: 10.1089/thy.2017.0026.
    PubMed     Abstract available


  317. ROBENSHTOK E, Nachalon Y, Benbassat C, Hirsch D, et al
    Disease Severity at Presentation in Patients with Disease-Related Mortality from Differentiated Thyroid Cancer: Implications for the 2015 ATA Guidelines.
    Thyroid. 2017 Aug 9. doi: 10.1089/thy.2017.0040.
    PubMed     Abstract available


  318. SUH CH, Choi YJ, Lee JJ, Shim WH, et al
    Comparison of Core-Needle Biopsy and Fine-Needle Aspiration for Evaluating Thyroid Incidentalomas Detected by 18F-FDG PET/CT: A Propensity Score Analysis.
    Thyroid. 2017 Aug 9. doi: 10.1089/thy.2017.0192.
    PubMed     Abstract available


  319. HA SM, Baek JH, Kim JK
    Detection of malignancy among suspicious thyroid nodules less than 1 cm on ultrasound with various thyroid image reporting and data systems.
    Thyroid. 2017 Aug 9. doi: 10.1089/thy.2017.0034.
    PubMed     Abstract available


    July 2017
  320. OH HS, Park S, Kim M, Kwon H, et al
    Young age and male sex can predict for a large-volume central neck lymph node metastasis in clinical N0 papillary thyroid microcarcinoma.
    Thyroid. 2017 Jul 25. doi: 10.1089/thy.2017.0250.
    PubMed     Abstract available


  321. ALHASHEMI A, Jones J, Goldstein DP, Santa Mina D, et al
    An Exploratory Study of Fatigue and Physical Activity in Canadian Thyroid Cancer Patients.
    Thyroid. 2017 Jul 16. doi: 10.1089/thy.2016.0541.
    PubMed     Abstract available


  322. HAHN SY, Shin JH, Oh YL, Kim TH, et al
    Role of Ultrasound in Predicting Tumor Invasiveness in Follicular Variant of Papillary Thyroid Carcinoma.
    Thyroid. 2017 Jul 12. doi: 10.1089/thy.2016.0677.
    PubMed     Abstract available


  323. PARK S, Kim WG, Han M, Jeon M, et al
    Thyroid-Stimulating Hormone Suppressive Therapy for Low-Risk Small Thyroid Cancer: A Propensity Score-Matched Cohort Study.
    Thyroid. 2017 Jul 12. doi: 10.1089/thy.2017.0177.
    PubMed     Abstract available


    June 2017
  324. KIYOTA N, Robinson B, Shah MH Md, Hoff AO, et al
    Defining Radioiodine-refractory Differentiated Thyroid Cancer: Efficacy and Safety of Lenvatinib by Radioiodine-refractory Criteria in the SELECT Trial.
    Thyroid. 2017 Jun 30. doi: 10.1089/thy.2016.0549.
    PubMed     Abstract available


  325. TANG AL, Falciglia M, Yang H, Mark JR, et al
    Validation of ATA Ultrasound Risk Assessment of Thyroid Nodules Selected for Ultrasound Fine Needle Aspiration.
    Thyroid. 2017 Jun 28. doi: 10.1089/thy.2016.0555.
    PubMed     Abstract available


  326. KLUBO-GWIEZDZINSKA J, Yang LA, Merkel R, Patel D, et al
    Results of screening in familial nonmedullary thyroid cancer.
    Thyroid. 2017 Jun 28. doi: 10.1089/thy.2016.0668.
    PubMed     Abstract available


  327. ITO Y, Onoda N, Ito KI, Sugitani I, et al
    Sorafenib in Japanese Patients With Locally Advanced or Metastatic Medullary Thyroid Carcinoma and Anaplastic Thyroid Carcinoma.
    Thyroid. 2017 Jun 21. doi: 10.1089/thy.2016.0621.
    PubMed     Abstract available


  328. KIM M, Kim WG, Oh HS, Park S, et al
    Comparison of the 7th and 8th Editions of the AJCC/UICC TNM Staging System for Differentiated Thyroid Cancer.
    Thyroid. 2017 Jun 21. doi: 10.1089/thy.2017.0050.
    PubMed     Abstract available


  329. MIYAUCHI A, Ito Y, Oda H
    Insights into the management of papillary microcarcinoma of the thyroid.
    Thyroid. 2017 Jun 19. doi: 10.1089/thy.2017.0227.
    PubMed     Abstract available


  330. SILVA-VIEIRA M, Carrilho-Vaz S, Esteves S, C Ferreira T, et al
    Second Primary Cancer in Patients with Differentiated Thyroid Cancer: Does Radioiodine Play a Role?
    Thyroid. 2017 Jun 14. doi: 10.1089/thy.2016.0655.
    PubMed     Abstract available


  331. YABUTA T, Matsuse M, Hirokawa M, Yamashita S, et al
    TERT promoter mutations were not found in papillary thyroid microcarcinomas that showed disease progression on active surveillance.
    Thyroid. 2017 Jun 14. doi: 10.1089/thy.2016.0645.
    PubMed     Abstract available


  332. PILLI T, Cantara S, Marzocchi C, Cardinale S, et al
    Diagnostic Value of Circulating microRNA-95 and -190 in the Differential Diagnosis of Thyroid Nodules: A Validation Study in 1000 Consecutive Patients.
    Thyroid. 2017 Jun 12. doi: 10.1089/thy.2017.0035.
    PubMed     Abstract available


    May 2017
  333. GONZALEZ HE, Martinez JR, Vargas S, Solar A, et al
    A 10-gene classifier for indeterminate thyroid nodules: Development and multicenter accuracy study.
    Thyroid. 2017 May 18. doi: 10.1089/thy.2017.0067.
    PubMed     Abstract available


  334. POLE JD, Zuk AM, Wasserman JD
    Diagnostic and Treatment Patterns among Children, Adolescents and Young Adults with Thyroid Cancer in Ontario: 1992-2010.
    Thyroid. 2017 May 17. doi: 10.1089/thy.2016.0629.
    PubMed     Abstract available


  335. RANDLE RW, Bushman NM, Orne J, Balentine CJ, et al
    PAPILLARY THYROID CANCER: THE GOOD AND BAD OF THE "GOOD CANCER".
    Thyroid. 2017 May 16. doi: 10.1089/thy.2016.0632.
    PubMed     Abstract available


  336. HAMAOKA Y
    Comment on "Comprehensive Survey Results of Childhood Thyroid Ultrasound Examinations in Fukushima in the First Four Years after the Fukushima Daiichi Nuclear Power Plant Accident".
    Thyroid. 2017 May 15. doi: 10.1089/thy.2016.0464.
    PubMed     Abstract available


  337. WILSON L, Huang W, Chen L, Ting J, et al
    Cost-Effectiveness of Lenvatinib, Sorafenib, and Placebo in the Treatment of Radioiodine Refractory Differentiated Thyroid Cancer.
    Thyroid. 2017 May 9. doi: 10.1089/thy.2016.0572.
    PubMed     Abstract available


  338. HEDMAN C, Djarv T, Strang P, Lundgren CI, et al
    The effect of thyroid-related symptoms on long-term quality of life in patients with differentiated thyroid carcinoma - a population-based study in Sweden.
    Thyroid. 2017 May 5. doi: 10.1089/thy.2016.0604.
    PubMed     Abstract available


  339. INIGUEZ ARIZA NM, Ryder M, Hilger CR, Bible KC, et al
    Salvage Lenvatinib Therapy in Metastatic Anaplastic Thyroid Cancer.
    Thyroid. 2017 May 4. doi: 10.1089/thy.2016.0627.
    PubMed     Abstract available


  340. KIM M, Kim WG, Park S, Kwon H, et al
    Growth Kinetics of Macronodular Lung Metastases and Survival in Differentiated Thyroid Carcinoma.
    Thyroid. 2017 May 2. doi: 10.1089/thy.2016.0676.
    PubMed     Abstract available


  341. HONG MJ, Na DG, Baek JH, Sung JY, et al
    Cytology-Ultrasonography (CU) Risk Stratification Scoring System Based on Fine-needle Aspiration Cytology and the Korean-Thyroid Imaging Reporting and Data System (K-TIRADS).
    Thyroid. 2017 May 2. doi: 10.1089/thy.2016.0603.
    PubMed     Abstract available


  342. TUTTLE RM MD, Haugen BR Md, Perrier N
    The Updated AJCC/TNM Staging System for Differentiated and Anaplastic Thyroid Cancer (8th edition): What changed and why?
    Thyroid. 2017 May 2. doi: 10.1089/thy.2017.0102.
    PubMed     Abstract available


  343. CHUNG SR, Baek JH, Park HS, Choi YJ, et al
    Ultrasound-Pathology Discordant Nodules on Core-Needle Biopsy: Malignancy Risk and Management Strategy.
    Thyroid. 2017;27:707-713.
    PubMed     Abstract available


    April 2017
  344. RUBIO GA, Koru-Sengul T, Vaghaiwalla TM, Parikh PP, et al
    Postoperative Outcomes in Graves' Disease Patients: Results from the Nationwide Inpatient Sample Database.
    Thyroid. 2017 Apr 29. doi: 10.1089/thy.2016.0500.
    PubMed     Abstract available


  345. OH HS, Kim WG, Park S, Kim M, et al
    Serial neck ultrasonographic evaluation of changes in papillary thyroid carcinoma during pregnancy.
    Thyroid. 2017 Apr 27. doi: 10.1089/thy.2016.0618.
    PubMed     Abstract available


  346. KIM H, Kim TH, Choe JH, Kim JH, et al
    Patterns of initial recurrence in completely resected papillary thyroid carcinoma.
    Thyroid. 2017 Apr 27. doi: 10.1089/thy.2016.0648.
    PubMed     Abstract available


  347. YANG Z, Flores J, Katz S, Nathan CA, et al
    Comparison of survival outcomes following post-surgical radioactive iodine versus external beam radiation in stage IV differentiated thyroid carcinoma.
    Thyroid. 2017 Apr 27. doi: 10.1089/thy.2016.0650.
    PubMed     Abstract available


  348. MA C, Feng F, Wang S, Fu H, et al
    Chinese data of efficacy of low- and high-dose of iodine-131 for the ablation of thyroid remnant.
    Thyroid. 2017 Apr 12. doi: 10.1089/thy.2015.0658.
    PubMed     Abstract available


  349. PAULSON VA, Shivdasani P, Angell TE, Cibas ES, et al
    Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features Accounts for More Than Half of "Carcinomas" Harboring RAS Mutations.
    Thyroid. 2017;27:506-511.
    PubMed     Abstract available


  350. MUJAMMAMI M, Tamilia M
    Response to Tulchinsky and Avram re: "Long-Term Outcomes of Patients with Papillary Thyroid Cancer Undergoing Remnant Ablation with 30 Millicurie Radioiodine".
    Thyroid. 2017;27:592.
    PubMed    


    March 2017
  351. IYAMA K, Matsuse M, Mitsutake N, Rogounovitch T, et al
    Identification of Three Novel Fusion Oncogenes, SQSTM1/NTRK3, AFAP1L2/RET, and PPFIBP2/RET in Thyroid Cancers of Young Patients in Fukushima.
    Thyroid. 2017 Mar 29. doi: 10.1089/thy.2016.0673.
    PubMed     Abstract available


  352. BONHOMME B, Godbert Y, Perot G, Alghuzlan A, et al
    Molecular pathology of anaplastic thyroid carcinomas: a retrospective study of 144 cases.
    Thyroid. 2017 Mar 28. doi: 10.1089/thy.2016.0254.
    PubMed     Abstract available


  353. TAVARELLI M, Sarfati J, Chereau N, Tissier F, et al
    Heterogeneous prognoses for pT3 papillary thyroid carcinomas and impact of delayed risk stratification.
    Thyroid. 2017 Mar 28. doi: 10.1089/thy.2016.0512.
    PubMed     Abstract available


  354. IZKHAKOV E, Barchana M, Liphshiz I, Silverman B, et al
    Trends of Second Primary Malignancy in Patients with Thyroid Cancer: A Population-Based Cohort Study in Israel.
    Thyroid. 2017 Mar 24. doi: 10.1089/thy.2016.0481.
    PubMed     Abstract available


  355. LANG BH, Woo YC, Chiu KW
    Single-Session High-Intensity Focused Ultrasound Treatment in Large-Sized Benign Thyroid Nodules.
    Thyroid. 2017 Mar 22. doi: 10.1089/thy.2016.0664.
    PubMed     Abstract available


  356. NICKEL B, Brito JP, Barratt A, Jordan S, et al
    Clinicians' Views on Management and Terminology for Papillary Thyroid Microcarcinoma: A Qualitative Study.
    Thyroid. 2017 Mar 21. doi: 10.1089/thy.2016.0483.
    PubMed     Abstract available


  357. SHAH SA, Adam MA, Thomas S, Scheri RP, et al
    Racial Disparities In Differentiated Thyroid Cancer: Have We Bridged The Gap?
    Thyroid. 2017 Mar 15. doi: 10.1089/thy.2016.0626.
    PubMed     Abstract available


  358. ZANELLA AB, Scheffel RS, Pasa M, Dora JM, et al
    The Role of Postoperative Stimulated Thyroglobulin as Prognostic Factor for Differentiated Thyroid Cancer in Children and Adolescents.
    Thyroid. 2017 Mar 14. doi: 10.1089/thy.2016.0559.
    PubMed     Abstract available


    February 2017
  359. MOON S, Song YS, Kim YA, Lim JA, et al
    Effects of Coexistent BRAFV600E and TERT Promoter Mutations on Poor Clinical Outcomes in Papillary Thyroid Cancer: A Meta-Analysis.
    Thyroid. 2017 Feb 9. doi: 10.1089/thy.2016.0350.
    PubMed     Abstract available


    January 2017
  360. XU B, Tallini G, Scognamiglio T, Roman BR, et al
    Outcome of large noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP).
    Thyroid. 2017 Jan 30. doi: 10.1089/thy.2016.0649.
    PubMed     Abstract available


  361. MURATA T, Iwadate M, Takizawa Y, Miyakoshi M, et al
    An adult mouse thyroid side population cell line that exhibits enriched epithelial-to-mesenchymal transition.
    Thyroid. 2017 Jan 27. doi: 10.1089/thy.2016.0130.
    PubMed     Abstract available


  362. GRIFFIN A, Brito JP, Bahl M, Hoang JK, et al
    Applying criteria of active surveillance to low-risk thyroid papillary cancer over a decade: How many surgeries and complications can be avoided?
    Thyroid. 2017 Jan 26. doi: 10.1089/thy.2016.0568.
    PubMed     Abstract available


  363. HAUGEN BR MD, Sawka AM, Alexander EK, Bible KC, et al
    The ATA Guidelines on Management of Thyroid Nodules and Differentiated Thyroid Cancer Task Force Review and Recommendation on the Proposed Renaming of eFVPTC without Invasion to NIFTP.
    Thyroid. 2017 Jan 23. doi: 10.1089/thy.2016.0628.
    PubMed     Abstract available


  364. CHOI YJ, Baek JH, Park HS, Shim WH, et al
    A computer-aided diagnosis system using artificial intelligence for the diagnosis and characterization of thyroid nodules on ultrasound: initial clinical assessment.
    Thyroid. 2017 Jan 10. doi: 10.1089/thy.2016.0372.
    PubMed     Abstract available


  365. ESZLINGER M, Bohme K, Ullmann M, Gorke F, et al
    Evaluation of a two-year routine application of molecular testing of thyroid fine needle aspirations (FNA) using a 7-gene-panel in a primary referral setting in Germany.
    Thyroid. 2017 Jan 10. doi: 10.1089/thy.2016.0445.
    PubMed     Abstract available


  366. ALEXANDER EK, Pearce EN, Brent GA, Brown RS, et al
    2016 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease during Pregnancy and the Postpartum.
    Thyroid. 2017 Jan 6. doi: 10.1089/thy.2016.0457.
    PubMed     Abstract available


  367. ITO M, Miyauchi A, Fujiwara M, Yoshioka W, et al
    Biochemical markers reflecting thyroid function in athyreotic patients on levothyroxine monotherapy.
    Thyroid. 2017 Jan 5. doi: 10.1089/thy.2016.0426.
    PubMed     Abstract available


  368. CAVALLO A, Johnson DN, White MG, Siddiqui S, et al
    Thyroid nodule size at ultrasound as a predictor of malignancy and final pathologic size.
    Thyroid. 2017 Jan 4. doi: 10.1089/thy.2016.0336.
    PubMed     Abstract available


  369. VAN DER WARDT RA, Persoon AC, Klein Hesselink EN, Links TP, et al
    Long-term follow-up for differentiated thyroid carcinoma patients - a reconsideration.
    Thyroid. 2017 Jan 3. doi: 10.1089/thy.2016.0314.
    PubMed     Abstract available


  370. AZMAT U, Porter K, Senter L, Ringel MD, et al
    Thyroglobulin Liquid Chromatography-Tandem Mass Spectrometry Has a Low Sensitivity for Detecting Structural Disease in Patients with Antithyroglobulin Antibodies.
    Thyroid. 2017;27:74-80.
    PubMed     Abstract available


    December 2016
  371. SHEN FC, Hsieh CJ, Huang IC, Chang YH, et al
    Dynamic risk estimates of outcome in Chinese patients with well-differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation.
    Thyroid. 2016 Dec 22. doi: 10.1089/thy.2016.0479.
    PubMed     Abstract available


  372. HAYMART MR, Pearce EN
    How Much Should Thyroid Cancer Impact Plans for Pregnancy?
    Thyroid. 2016.
    PubMed     Abstract available


    November 2016
  373. PARK S, Kim WG, Song E, Oh HS, et al
    Dynamic Risk Stratification for Predicting Recurrence in Patients with Differentiated Thyroid Cancer Treated without Radioactive Iodine Remnant Ablation Therapy.
    Thyroid. 2016.
    PubMed     Abstract available


  374. SHAHA MA, Wang LY, Migliacci JC, Palmer FL, et al
    Previous external beam radiation treatment exposure does not confer worse outcome for patients with differentiated thyroid cancer.
    Thyroid. 2016.
    PubMed     Abstract available


  375. RAKHLIN L, Fish S, Tuttle RM Md
    Response to therapy status is an excellent predictor of pregnancy-associated structural disease progression in patients previously treated for differentiated thyroid cancer.
    Thyroid. 2016.
    PubMed     Abstract available


  376. JI Q, Shi R, Qu N, Luo T, et al
    Programmed death-ligand 1 expression in papillary thyroid cancer and its correlation with clinicopathological factors and recurrence.
    Thyroid. 2016.
    PubMed     Abstract available


  377. ALZAHRANI AS, Murugan AK, Qasem E, Alswailem M, et al
    Single Point Mutations in Pediatric Differentiated Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Abstract available


  378. RAGO T, Scutari M, Loiacono V, Santini F, et al
    Low elasticity of thyroid nodules at ultrasound elastography is correlated with malignancy, degree of fibrosis and high expression of galectin-3 and fibronectin-1.
    Thyroid. 2016.
    PubMed     Abstract available


    October 2016
  379. CASTELBLANCO E, Zafon C, Maravall J, Gallel P, et al
    APLP2, RRM2 and PRC1: new putative markers for the differential diagnosis of thyroid follicular lesions.
    Thyroid. 2016.
    PubMed     Abstract available


  380. RABINOWITS G, Barletta J, Sholl LM, Reche E, et al
    Successful Management of a Patient with Malignant Thyroid Teratoma.
    Thyroid. 2016.
    PubMed     Abstract available


  381. JEONG HS, Choi EK, Song IU, Chung YA, et al
    Differences in brain glucose metabolism during preparation for I-131 ablation in thyroid cancer patients: Thyroid hormone withdrawal versus recombinant human thyrotropin.
    Thyroid. 2016.
    PubMed     Abstract available


  382. MERTEN MM, Castro MR, Zhang J, Durski JM, et al
    Examining the Role of Preoperative Positron Emission Tomography/Computerized Tomography (PET/CT) in Combination with Ultrasonography in Discriminating Benign from Malignant Cytologically Indeterminate Thyroid Nodules.
    Thyroid. 2016.
    PubMed     Abstract available


  383. WANG Q, Yang H, Wu L, Yao J, et al
    Identification of Specific Long Non-Coding RNA Expression: Profile and Analysis of Association with Clinicopathological Characteristics and BRAF-mutation in Papillary Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Abstract available


  384. BHALLA S, Monga D, Soni T, Gaurang A, et al
    Competency Education of Primary Care Physicians in Management of Thyroid Disorders: Implementation Experiences from a Pan India Certificate Course.
    Thyroid. 2016.
    PubMed     Abstract available


  385. ROSSING RM, Jentzen W, Nagarajah J, Bockisch A, et al
    Serum thyroglobulin doubling time in progressive thyroid cancer.
    Thyroid. 2016.
    PubMed     Abstract available


  386. LEE SG, Lee WK, Lee HS, Moon J, et al
    Practical Performance of the 2015 American Thyroid Association Guidelines for Predicting Tumor Recurrence in Patients with Papillary Thyroid Cancer in South Korea.
    Thyroid. 2016.
    PubMed     Abstract available


  387. GAVRILA A, Hasselgren PO, Glasgow A, Doyle AN, et al
    Variable Cold-induced Brown Adipose Tissue Response to Thyroid Hormone Status.
    Thyroid. 2016.
    PubMed     Abstract available


  388. NAJAFIAN A, Noureldine SI, Azar F, Atallah C, et al
    RAS Mutations, RET/PTC and PAX8/PPAR-gamma Chromosomal Rearrangements Are Also Prevalent in Benign Thyroid Lesions? Implications Thereof and, A Systematic Review.
    Thyroid. 2016.
    PubMed     Abstract available


  389. TULCHINSKY M, Avram A
    Long-Term Outcomes of Patients with Papillary Thyroid Cancer Undergoing Remnant Ablation with 30 Millicurie Radioiodine: Patient Cohort Definition Makes No Sense.
    Thyroid. 2016.
    PubMed     Abstract available


    September 2016
  390. AHN HS, Kim HJ, Kim KH, Lee YS, et al
    Thyroid cancer screening in South Korea increases detection of papillary cancers with no impact on other subtypes or thyroid cancer mortality.
    Thyroid. 2016.
    PubMed     Abstract available


  391. REN Y, Lence-Anta JJ, Pereda C, Chappa M, et al
    Foxe1 Polymorphism Interacts with Dietary Iodine Intake in Differentiated Thyroid Cancer Risk in the Cuban Population.
    Thyroid. 2016.
    PubMed     Abstract available


  392. SINGER S, Husson O, Tomaszewska IM, Locati L, et al
    Quality of life priorities in patients with thyroid cancer - a multi-national EORTC phase I study.
    Thyroid. 2016.
    PubMed     Abstract available


  393. YOUNGWIRTH L, Abdelgadir Adam M, Scheri R, Roman S, et al
    Extrathyroidal Extension is Associated with Compromised Survival in Patients with Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Abstract available


    August 2016
  394. WILTSHIRE JJ, Drake TM, Uttley L, Balasubramanian SP, et al
    Systematic Review of Trends in the Incidence Rates of Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Abstract available


  395. IPPOLITO S, Ippolito R, Peirce C, Esposito R, et al
    Recombinant Human Thyroid Stimulating Hormone Improves Endothelial Coronary Flow Reserve in Thyroidectomized Patients With Differentiated Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Abstract available


  396. ESPINOSA DE YCAZA AE, Lowe KM, Dean DS, Castro MR, et al
    Risk of Malignancy in Thyroid Nodules with Non-diagnostic Fine Needle Aspiration: A Retrospective Cohort Study.
    Thyroid. 2016.
    PubMed     Abstract available


  397. PIRES B, Alves-Junior PA, Bordallo MA, Bulzico DA, et al
    Prognostic factors for early and long-term remission in pediatric differentiated thyroid cancer: the role of gender, age, clinical presentation and the newly proposed American Thyroid Association risk stratification system.
    Thyroid. 2016.
    PubMed     Abstract available


  398. ONODA N, Sugino K, Higashiyama T, Kammori M, et al
    The safety and efficacy of weekly paclitaxel administration for anaplastic thyroid cancer patients: A nationwide prospective study.
    Thyroid. 2016.
    PubMed     Abstract available


  399. NIXON IJ, Simo R, Newbold K, Rinaldo A, et al
    Management of Invasive Differentiated Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Abstract available


    July 2016
  400. CUI K, Zhang M, Fu C, Ma X, et al
    Comment on "Partially Cystic Thyroid Nodules on Ultrasound: Probability of Malignancy and Sonographic Differentiation".
    Thyroid. 2016.
    PubMed    


  401. STRICKLAND KC, Vivero M, Jo VY, Lowe AC, et al
    Pre-operative Cytologic Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features (NIFTP): A Prospective Analysis.
    Thyroid. 2016.
    PubMed     Abstract available


  402. ZHANG M, Luo Y, Zhang Y, Tang J, et al
    Efficacy and safety of ultrasound guided radiofrequency ablation for treating low risk papillary thyroid microcarcinoma: a prospective study.
    Thyroid. 2016.
    PubMed     Abstract available


  403. RATZON NZ, Uziely B, de Boer AG, Rottenberg Y, et al
    Unemployment risk and decreased income 2 and 4 years after thyroid cancer diagnosis: a population based study.
    Thyroid. 2016.
    PubMed     Abstract available


    June 2016
  404. HYUN YG, Alhashemi A, Fazelzad R, Goldberg AS, et al
    A Systematic Review of Unmet Information and Psychosocial Support Needs of Adults Diagnosed with Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Abstract available


  405. MALANDRINO P, Russo M, Regalbuto C, Pellegriti G, et al
    The Outcome Of The Diffuse Sclerosing Variant of Papillary Thyroid Cancer: A Meta-Analysis.
    Thyroid. 2016.
    PubMed     Abstract available


  406. BERNSTEIN MB, Chang EL, Amini B, Pan H, et al
    SPINE STEREOTACTIC RADIOSURGERY FOR PATIENTS WITH METASTATIC THYROID CANCER - Secondary analysis of Phase I/II trials.
    Thyroid. 2016.
    PubMed     Abstract available


  407. VALDERRABANO P, Montilla Soler J, Mifsud MJ, Leon ME, et al
    Hypermetabolism on 18F-FDG PET scan does not influence the interpretation of thyroid cytopathology and nodules with SUVmax <2.5 are not at increased risk for malignancy.
    Thyroid. 2016.
    PubMed     Abstract available


  408. BRITO JP, Bleyer A
    Impact of thyroid cancer on the incidence and survival of adolescents and young adults with cancer.
    Thyroid. 2016.
    PubMed    


  409. HIRSCH D, Shohat T, Gorshtein A, Robenshtok E, et al
    Incidence of Non-thyroidal Primary Malignancy and the Association with I-131 Treatment in Patients with Differentiated Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Abstract available


  410. GULEC SA, Kuker RA
    The Clinical Value of I-124 PET/CT Imaging in Thyroid Cancer.
    Thyroid. 2016.
    PubMed    


  411. SHRESTHA RT, Evasovich MR, Amin K, Radulescu A, et al
    Correlation between Histological Diagnosis and Mutational Panel Testing of Thyroid Nodules - A Two Year Institutional Experience.
    Thyroid. 2016.
    PubMed     Abstract available


  412. WHITE MG, Cipriani NA, Abdulrasool L, Kaplan SP, et al
    Radiation Induced Differentiated Thyroid Cancer Is Associated with Improved Overall Survival but Not Thyroid Cancer-Specific Mortality or Disease Free Survival.
    Thyroid. 2016.
    PubMed     Abstract available


  413. JINDAL A, Khan U
    Is Thyroglobulin level by LC-MS/MS always reliable for follow-up of DTC after Thyroidectomy: A report of 2 cases.
    Thyroid. 2016.
    PubMed     Abstract available


  414. PANI F, Atzori F, Baghino G, Boi F, et al
    HYPOTHYROIDISM AND THYROID AUTOIMMUNITY AS A PROGNOSTIC BIOMARKER OF BETTER RESPONSE IN METASTATIC CANCER LONG SURVIVORS TREATED WITH SUNITINIB.
    Thyroid. 2016.
    PubMed     Abstract available


  415. ANDERSON K, Youngwirth L, Scheri R, Stang M, et al
    T1a vs T1b Differentiated Thyroid Cancers: Do We Need to Make the Distinction?
    Thyroid. 2016.
    PubMed     Abstract available


  416. CAMPENNI A, Giovanella L, Siracusa M, Alibrandi A, et al
    99mTc-METHOXY-ISOBUTYL-ISONITRILE (MIBI) SCINTIGRAPHY IS A USEFUL TOOL FOR ASSESSING THE RISK OF MALIGNANCY IN THYROID NODULES WITH INDETERMINATE FINE NEEDLE CYTOLOGY (FNAC).
    Thyroid. 2016.
    PubMed     Abstract available


  417. SHARMA A, Jasim S, Reading CC, Ristow K, et al
    Clinical Presentation and Diagnostic Challenges of Thyroid Lymphoma - A Cohort Study.
    Thyroid. 2016.
    PubMed     Abstract available


  418. RUIZ-FERRER M, Fernandez RM, Navarro E, Antinolo G, et al
    The G534E variant in <i>HABP2</i> and Nonmedullary Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Abstract available


    May 2016
  419. KIST JW, de Keizer B, Vogel WV
    Letter to the Editor regarding the article "I-124 PET/CT in patients with differentiated thyroid cancer: clinical and quantitative image analysis".
    Thyroid. 2016.
    PubMed    


  420. HODAK S, Tuttle RM Md, Maytal G, Nikiforov YE, et al
    Changing the Cancer Diagnosis - the Case of Follicular Variant of Papillary Thyroid Cancer Primum, Non Nocere and NIFTP.
    Thyroid. 2016.
    PubMed     Abstract available


  421. WU JX, Young S, Hung M, Li N, et al
    Clinical Factors Influencing the Performance of Gene Expression Classifier Testing in Indeterminate Thyroid Nodules.
    Thyroid. 2016.
    PubMed     Abstract available


  422. GOLDFARB M, Casillas J
    Thyroid Cancer Specific Quality of Life and Health Related Quality of Life in Young Adult Thyroid Cancer Survivors.
    Thyroid. 2016.
    PubMed     Abstract available


  423. MUJAMMAMI MH, Hier MP, Payne RJ, Rochon L, et al
    Long-term Outcomes of Patients with Papillary Thyroid Cancer undergoing Remnant Ablation with 30 milliCuries Radioiodine.
    Thyroid. 2016.
    PubMed     Abstract available


    April 2016
  424. CAZARIN JM, Coelho RG, Hecht F, Andrade BM, et al
    5 -AMP-activated Protein Kinase (AMPK) Regulates Papillary (TPC-1 and BCPAP) Thyroid Cancer Cell Survival, Migration, Invasion and Epithelial-to-Mesenchymal Transition.
    Thyroid. 2016.
    PubMed     Abstract available


  425. LA COUR JL, Andersen UB, Sorensen CH, Nygaard B, et al
    Radioiodine Therapy Does Not Change the Atherosclerotic Burden of the Carotid Arteries.
    Thyroid. 2016.
    PubMed     Abstract available


  426. HAKALA TT, Kholova I
    Changes in classification of follicular thyroid cancers.
    Thyroid. 2016.
    PubMed     Abstract available


    March 2016
  427. BRITO JP, Kim HJ, Han SJ, Lee YS, et al
    Geographic distribution and evolution of thyroid cancer epidemic in South Korea.
    Thyroid. 2016.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: